EXECUTIVE SUMMARY
Biotechnology plays a critical role in the growth of Indian knowledge economy. Biotech sector has
a direct impact on the well-being of mankind and has the potential to transform as many lives as
possible, create opportunities and ensure holistic development for all. Biotechnology sector – thesunrise sector is recognized as one of the key drivers for contributing to India's economy target of
USD 5 Trillion by 2025, and poised to grow exponentially over the next decade. Policy initiatives ofGovernment of India such as Make-in-India scheme are aimed to develop India as a world-class
Bio-manufacturing hub. India is among the top 12 destinations for biotechnology in the world and3rd in Asia-Pacific. With Global Innovation Index improving to 46th rank in the backdrop, India’s bioeconomy is growing in double digits Year on Year, from $51 Bn in 2018 to $81 Bn in 2021. BIRAC
has been nurturing the biotech ecosystem in the country over these 10 years aligning with the
National Missions of Startup India and Make-in-India. Today, there are 5000+ biotech start-ups inthe country i.e., a 10x growth from 2012. This compendium is a compilation of some of the BIRAC
supported innovations, products and technologies and brings to you an insight into the innovative
products and technologies supported by BIRAC and how these innovations have come a long way
in solving problems in varied sectors. This rich repository provides insights into key biotechnological innovations supported and closely mentored by BIRAC and its partners. This vibrant ecosystemgives us the confidence that our innovators will be recognized globally for developing solutions
addressing major societal problems.
We wish the innovators a successful path ahead!

INDEX
ProfilePg.
No.

ProfilePg.
No.

Abonics India Private Limited

1

Duosis Bio-Innovations Pvt Ltd

35

Abyom SpaceTech and Defence Private Limited 2

Earthtech Innovations Pvt Ltd.

36

Adit Bioscience private Limited

3

Embright Infotech Private Limited

37

Agropeeper Technologies Private Limited

4

Ensect Farm Pvt Ltd

38"AIRR ORGANICS AND BIOFERTILIZERSPVT LITD"

5

Epanipurii kartz

39

Aodh Lifesciences Pvt Ltd

6

Epygen Biotech PVT LTD

40

Apramitha Innovations Private Limited

7

Exsure Pvt Ltd

41

Ardor Biomed India PVT LTD

8

Farm Gulp Pvt. Ltd.

42

ARISTA VAULT (Arivation Fashiontech Pvt Ltd)

9

Fermentech Labs Pvt. Ltd

43

Asadel Technologies Pvt Ltd

10

FIBROHEAL WOUNDCARE PVT LTD

44

Aspartika Biotech

11

Flic Farm Pvt Ltd (XMachines)

45

ATATRI Design

12

FOOTPRO SOLUTIONS PVT LTD

46

Auflows CardioTech Pvt Ltd

13

Foundation for Neglected Disease Research(FNDR)

47

Aumeesh Tech Pvt Ltd

14

Foundry Medical Technologies Pvt Ltd

48

Aves Foodtech Private Limited, Pune

15

Galanto Innovations Pvt Ltd

49

Bagmo Private Limited

16

Garveish Herbaceuticals Private Limited

50

BarifloLabs Pvt Ltd

17

Generation Net Nutrition Private Limited

51

BhoomiCam Private Limited

18

Genomiki Solutions Private Limited

52

Billion Carbon Solutions Private Limited

19

Godaam Innovations Pvt. Ltd.

53

Biodimension Technology Pvt Ltd

20

Health Sensei India Pvt Ltd.

54

Biopioneer Pvt. Ltd

21

HELO HEALTH TM Adarsa Private Limited

55

Bioscan Research Pvt. Ltd

22

Heyan Health Solution Pvt. Ltd.

56

Blackfrog Technologies Pvt.Ltd

23

Himalayan Hemp Industries Pvt. Ltd

57

BoviEdge Research LLP

24

Hospito58

Bramhansh Technologies Pvt Ltd

25

IAPS Agritech Pvt Ltd

59

Chem Life Innovations

26

In Dhan Pay Gate Pvt. Ltd.

60

Cleome Innovations

27

Innovative Scripts Private Limited

61

CoderFarm Private Limited

28

InterCosmos

62

Coexin Technologies Healthcare Private Limited

29

Intisen Technology Pvt Ltd

63

Craste30

IOTA DIAGNOSTIC PVT. LTD

64

Cuor Stem Cellutions Pvt Ltd

31

ipanelKlean Solar Pvt Ltd.

65

Cutting Edge Medical Devices Pvt. Ltd.

32

iRefill66

DNA Nano biosensor for TB detection

33

Janitri Innovations

67

Drone Adda

34

JC OrthoHeal Pvt Ltd.

68

Jouls Ecotech Pvt. Ltd

69

INDEX
ProfilePg.
No.

ProfilePg.
No.

Kidaura Innovations Pvt. Ltd.

70

REVY Environmental Solutions Pvt. Ltd

106

Knowledgepie Pvt. Ltd.

71

Rigel Bio Environ Solutions Pvt. Ltd.

107

Krimmi Biotech LLP

72

Krisham Healthcare73

RONCOV Diagnostics and Therapeutics Pvt.
Ltd

108

Kwaklei and Khonggunmelei Orchids Pvt. Ltd

74

RUT3

109

Lab Iconics Technologies LLP

75

Ryot Agro Private Limited

110

Life and Limb Private Limited

76

Samasti Health Technologies Pvt Ltd

111

List App Pharmatech Pvt. Ltd.

77

SAVEMOM PRIVATE LIMITED

112

Machphy Solutions

78

SCYLENE TECHNOLOGY AND LIFE SCIENCES
PVT LTD.

113

Manastik Technologies Pvt. Ltd.

79

SEGS India

114

mBioSys Private Limited

80

Sengathalibiofiber Pvt Ltd

115

Medic Tech Pvt Ltd

81

Shankaranarayana Life Sciences LLP

116

Mediklik Webhealth Pvt Ltd

82

SharingMitra Foundation

117

Medlarks Private Limited

83

Simplismart

118

MedPrime Technologies Pvt. Ltd.

84

Sinewavs

119

MEEALANTAAS (M-TAAS) Pvt. Ltd.

85

SMART Home Health care Solutions Pvt Ltd

120

Natswear Pvt Ltd

86

SNRASSYSTEMS

121

Natural bioceramics Pvt Ltd

87

STEAMedu LEARNING PRIVATE LIMITED

122

Nawgati Tech Private Limited

88

Swab Nanosolutions Private Limited

123

Neontram Pvt. Ltd

89

Swapeco Solutions Pvt. Ltd.

124

Netraum Ayurveda

90This Life Matters Pvt Ltd

125

Nutrixeric LLP

91

ONEOMICS PRIVATE LIMITED

92

Tishyas Medical Device Development Solutions Pvt Ltd

126

Onward Assist

93

Trestle Labs | Kibo

127

Panakeia Medisys Pvt Ltd

94

Tvachan Organics

128

PhotoSpIMeDx Private Limited

95

UNINO Healthcare Private Limited

129

Plabeltech Private Limited

96

Urban Air Labs

130

Plabeltech Private Limited

97

Utopic Tech

131

Primary Healthtech Pvt Ltd

98

Vel Natural fibers

132

Primogen Biotech Private Limited

99

Velmenni R&D Pvt Ltd

133

Primogen Biotech Private Limited

100

Verdant Impact

134

Prognostics In-med Pvt Ltd

101

Vizola Ed-tech solutions

135

ProPlant Foods Pvt Ltd (ProMeat)

102

Xefficient Pvt Ltd

136

Quantrello Digital Private Limited

103

Yuvitel Technologies Pvt Ltd

137

Reinste Nano Ventures Private Limited

104

Zevyu Energy Pvt. Ltd.

138

Renergizr Industries Pvt. Ltd.

105

Startup Name

Product/Technology

Abonics India Private Limited

Smart Educational laboratory Equipment & Apparatus

Present stage of Development
Minimum Viable ProductUnique Selling Point: : Easy to Use and transport, Light in weight, costeffective, Transparent from the top of product to give good visibility for theexperiment being carried out

Geographical Region Targeted:
Uttar Pradesh & Delhi

Product Positioning: NA
National/Societal relevance: IRural/urban inequalities are also a major
obstacle to sustainable development. Our startup has played a major impact
on rural economy as we know poverty is mainly a rural phenomenon since
70% of the world’s poor are rural (IFAD, 2001).As our startup belongs toedtech category ,we have launched various skill & personality development
programs and workshops for the rural students so that they can learn andgrow themselves both via online and offline mode. We are also providing
practical training to rural students for the subjects like physics, chemistry,
biology, electronics from primary education to higher education. As we know
rural economy contributes 46% towards the national income and 25-30% of
India’s GDP, So edtech industry is playing a major role in rural development,
Our startup is boosting the rural economy by providing better education andfacility to the students

Cost:
Rs. 500 to Rs. 3000

Units sold:60
IP Status:
Under ProcessedyImport Substitution: YesyExport Potential: Per Month 1000 Units.
Product PictureyContact detail

Mobile No: : +91 8933862239,
7706959266

WebsiteMajor Achievements(including awards):
Recognized by Department of
Promotion Industries and Trade(DPIIT), Startup India and Start in UP
andAwarded by 105th Indian Science
Congress, India International Science
Festival,
National
Educational
Society, National Children’s Science
Congress, Regional Science andTechnology Center,
Winner of IIC REGIONAL MEET 2022
organized by AKTU Lucknow

www.abonicsindia.com

1

2

3

Product/Technology

Startup Name

AI based Quality Assessment and
Shelf-Life Evaluation of Fruits

Agropeeper Technologies Private Limited

Present stage of Development
Developing a prototype (Validation)

Unique Selling Point: Our system is automatic, based on external and internal
characteristics (damages and maturity) of fruits with handy device; whereas
competitive systems presently available are mostly based on the externalparameters of produce and requires a lot of human intervention.

Geographical Region Targeted:
Initially Maharashtra

Product Positioning:yNon-invasive, non-destructive and contactless technique adopted for
fruit assessmentyApplicability of our product assessing the fruits as well as vegetablesyPre-assessment reports available on the device itself

Cost:
Rs 75,000/- ( minimum 3 units required
per hospital)

Units sold:30

National/Societal relevance:yEnvironmental value: Preserving the environment due to reduction in
post-harvest losses/wastesySocial value: Contributing to the Doubling Farm Income strategy due toreduction in post-harvest losses/wastesyEconomic value: Improves product quality, increases export efficiency
thus ultimately increasing farmers economy.

IP Status:• Indian Patent Granted on Dec 2020
• International Patent Status
1. US Patent Filed
2. Europe Patent FiledyyyImport Substitution: Yes
Export Potential: Yes
Product PictureyContact detail

4

Mobile No: : +91 9224685068

Major Achievements(including awards):
Winner MSME Idea Hackathon 2022
BIRAC BIG-20 grantee 2022
RKVY-RAFTAAR grantee supportedby Ministry of Agriculture & Farmer
WelfareSelectedby
Women
Entrepreneurship
Cell(WEC),
Maharashtra State Innovation
Society (MSInS) to get incubation
support from StartupNexus

Emailvarshabhole83@gmail.com

Websitewww.agropeepertechnologies.com

Startup Name

Product/Technology

AIRR ORGANICS AND BIOFERTILIZERSPVT LITD

AIRR AISHWARYA ARKA MICROBIAL CONSORTIUM (AMC)

Unique Selling Point: Product is powered by technology, jointly developed &researched by Indian Institute of Horticultural Research (IIHR) & ICAR-Delhi.
Technology is tested on varied crops under varied climatic conditions.
Product Positioning: Applicable to all horticultural crops such as vegetables,
fruits, flowers, Ornamental plants, spices & plantation crops
National/Societal relevance: The technology created job opportunities& young entrepreneurs Increased income of farmers by reducing cost ofcultivation Will improve food security
Import Substitution: The technology reduces the import of inorganic
fertilizers, like Urea & DAP etc., in agricultural sector
Export Potential: The product can be exported to developing countries
subjected to necessary approvals from competent authority.

Geographical Region Targeted:
Currently, Southern Parts ofIndia (Karnataka, Tamil Nadu,
Andhra Pradesh, Telangana,
Kerala & Maharashtra). Further,targeting Pan India
Cost:
Liquid Rs 273/Liter
Solid Rs 147/Liter

Units sold:
Liquid approximately 10,000 liters
Solid approximately 14 tons.
Product Picture

AIRR AISHWARYA Liquid 5L/1L

Contact details

Present stage of Development
Commercialization & Marketing

AIRR AISHWARYA Solid 5Kg/1Kg

Mobile No: : +91 8660761810

Websitewww.airrbiofertilizers.com

5Product/Technology

Startup Name
Aodh Lifesciences Pvt Ltd

Nebulization suspension for Pneumonia to fight Anti-microbial
Resistance (AMR)

Unique Selling Point: Targeted delivery at site, rapid clinical response andcombat AMR
Product Positioning: Critical care and ICU
National/Societal relevance: India is on top list with Drug Resistance Index
at 79
Import Substitution: N/A

Present stage of Development
TRL-6; Progressing to Clinical trial
phase 3
Geographical Region Targeted:
India
Cost:
INR 150

Export Potential: To USA & European countries

Units sold:
N/A

Product Picture

IP Status:
Filed 7 patents and granted 3 patents
Major Achievements(including awards):
Best Innovation Award from
Government of Telangana. Among top
20 in Stanford Seed Spark Cohort-04
offered by Stanford Graduate School ofBusiness, USA

Contact detail

6

Mobile No: : +91 9908373343

EmailWebsitewww.aodhlifesciences.inStartup Name
Apramitha Innovations Private
Limited, Hyderabad

Product/Technology
PDE4i topical dosage forms to treat chronic diseases likepsoriasis & dry eye disease

Unique Selling Point: Long-term safe treatment option for chronic diseases.
Product Positioning: Safe long-term treatment option for a chronic disease
like psoriasis.
National/Societal relevance: More than 2-3% of the population is affected bypsoriasis and about 70% among them are mild to moderate. The prevalenceof DED in India is higher than the global prevalence and ranges from 18.4% to
54.3%
Export Potential: Significant potential in emerging markets and US/EU.
Product Picture:

Present stage of Development
Formulation and analytical method
development completed, positive preclinical efficacy results and safety datafor 90 days, promising prototype clinical data, DCGI approval for the conductof phase 3 clinical study, more than
50% of patient screening completed.
Geographical Region Targeted:
India and subsequently
emerging markets.
Cost:
About INR 400 per unit. Approximately
INR 5000 for total treatment.
Units sold:
Under Phase 3 clinical study andtargeted to launch during the second
half of 2023. Year 1: 3,00,000 units, Year
2: 5,00,000 units, Year 3: 10,00,000
units

Figure 1: Improvement in disease before and after
treatment with proposed PDE4i topical dosage forms.

IP Status:
Patent filled : 202041053550,
Patent Granted IN301416
Major Achievements(including awards):
Granted fund under BIG scheme from
BIRAC.

Figure 2: Comparison of tear volume of the proposed PDE4i topical dosage
forms with the commercially approved product before and after treatment

Contact details

Sreedharala Venkata Nookaraku
Mobile No: 9959097353

EmailWebsitevsreedharala@apramitha.com
www.apramitha.com

7

Startup Name

Product/Technology

Ardor Biomed India PVT LTD

Bacterial Cellulose based advanced wound patch

Present stage of Development
Product is in advanced Human
Trials stage

Unique Selling Point: Employs agro waste matured coconut water forsynthesizing the patch and incorporates coconut derivatives for anti-microbial
properties
Product Positioning: Product is intended for diabetic patients in low-income
regions.
National/Societal relevance: Our product will help to offset reliance ofimported products for similar usage. Will also help in bringing in a source ofincome for rural communities engaged in the coconut processing industry.

Geographical Region Targeted:
Product has a global target audience.
Specifically developing countries for costeffective wound care solution

Cost:
Rs.200 per 10X10 patch

Import Substitution: Will help to substitute import of similar wound careproducts for diabetic patients

Units sold:
NA

Export Potential: Has huge potential for export specifically to several East
Asian and African countries as diabetic ulcers is a major issue and a relatively
cheap alternative is non existent.

IP Status:
IP filed, Free to Operate assured

Product Picture
y
y
y

y
y
y
y
y

y

Contact detail8

Vivekanand K
Mobile No: : +91 9944951234

Major Achievements(including awards):

SEED grant by DPIIT to the tune of 10
lakhs
BIG grant by BIRAC to the tune of 50
lakhs
Recognized as one among top 75
startups in India to celebrate 75 years
of Indian Independence and scientificdevelopment with our products
displayed in Vigyan Bhavan
Only Indian company to be shortlisted
for Hello Tomorrow Asia-pacific deep
tech challenge held at Singapore
Winner of Ramaiah Evolute "StarStartup Awards" for the year 2022
Products patented and trademarked
Traction already received from a global
wound care brandSeveral allied products have been
conceived in Cosmeceutical and foodsupplement segments. These products
have been scientifically validated
through 3rd party and enteringcommercialization within very soon.
Patent applied.
Nasscom t4g - Technology for good
- Finalists 2019

Emailvivek@ardorbiomed.com

Websitewww.ardorbiomed.com

Startup Name

Product/Technology

ARISTA VAULT (Arivation Fashiontech Pvt Ltd)IOT | NBIOT | 5G

Unique Selling Point: Smart tech gadget with power button
Product Positioning: India’s First Smart Wallet/Luggage | Vault safety series| Consumer tech.
National/Societal relevance: Safety security of people’s Wealth, Data,belonging, & near ones.

Present stage of Development
Scaling up
Geographical Region Targeted:
Indian Urban, City, Metros, Tier2
Cost:
5500/- per unit)

Export Potential: Exported to US, UAE, potential UK & Germany.

Units sold:
20,000

Product Picture

IP Status:
5 patent filed 1 international patent,
pending

Major Achievements(including awards):
YourStory recognition 2023 as India’sFirst Smart Luggage Brand, Star Awards
for most innovative product, Amazon’saward for Emerging brand of India.
3.59crore revenue generated. F.Y. 21-22

Contact detail

Mobile No: : +91 8770375937

Emailaristavault@gmail.com

Websitewww.aristavault.com

9

Product/Technology

Startup Name

ML/DL based AI platform to aid (a) clinical screening & assessment of neuro- degenerative conditions in elderly population, (b) vocal bio-markers for detection of dementia stages,(c) FRS for criminal tracking & forensic

Asadel Technologies Pvt Ltd

Unique Selling Point: Fast, light-weight, scalable & affordable

Present stage of Development
PoC to Early revenue

Product Positioning: Primarily in secondary & tertiary health centres
National/Societal relevance: With increasing number of elderly populations,early detection & assessment of dementia would help control the condition.
It will also help/assist paramedics (Asha workers) at remote corners (whereavailability of doctors is thin) to sensitize patients/subjects.
Import Substitution: Import of Walking Strips
Export Potential: High in MENA, Nepal (initial discussions).

Geographical Region Targeted:
Currently pan India
Cost:
Software License Fee per user startingfrom INR 50,000
Units sold:40+

Product Picture

IP Status:
Under Process
Major Achievements(including awards):
IHW Digital Health Award 2021,
Nominated to present solutions at 10th
& 11th International IT Forum, SCO& BAARC Summit, Khanty Mansiysk,
RussiaContact detail

10

Email

partha@asadeltech.com

Websitehttps://www.asadeltech.com

Startup Name
Aspartika Biotech

Product/Technology
A Zero Waste discharge technology for large scale production of Omega 3 Fatty
Acids, Designer Eggs & Protein Supplement from Discarded Silkworm Pupa Waste
Present stage of Development
Commercialization

Unique Selling Point: Novel source of omega and protein (Insect protein),
Novel and zero waste discharge process of extraction (Supercritical extraction).

Geographical Region Targeted:
South India

Product Positioning: For Silkworm industry, Aspartika Biotech is market
leader who have developed a novel technology to utilize silkworm pupa to
products like insect protein and omega rich oil, thus generating income for thesilk reeling farmers and reducing environmental pollution.

Cost:
5500

For poultry feed manufacturers, Aspartika Biotech are innovative feed
manufacturers, have provide novel feed supplement, silkworm pupa oil andprotein which will replace soya meal and thus reducing their dependency ofsoya meal.
National/Societal relevance: We have successfully trained women farmers incollection and primary processing of silkworm pupa thus generating income
for them. This process has reduced waste discharge and improved the livesof people in the area. The primary processing of silkworm pupa is a scalable
process and can be trained to an unskilled person which in turn decentralizes
the process and makes it resilient for the farmers.

Units sold:
2500
IP Status:
Patent filed: 3965/CHE/2015

1.

Around 1,00,000 MT of silkworm pupa waste is generated in India, and it
is an environmental hazard, which has foul odour and attracts other pests.
If completely collected and processed, it can cater to 29 million Children’s
Omega-3 needs for an entire year in India.
Import Substitution: Omega rich oils like fish oil, soyabean meal and fish meal
Export Potential: Market potential in Bangladesh, Japan, China and European
markets.

2.

Product Picture
3.

4.

5.

Contact details

Mobile No: : +91 953873036

WebsiteMajor Achievements(including awards):
BiotechProduct,
Process
Development & Commercialization
Award-2020 in the Private
Organization Category, On the eventof BIRAC’s 9th Foundation Day
Presided by
Dr. Harsh
Vardhan, Hon’ble Union Minister for
Science & Technology, Earth Science& Health.
2022 Meaningful Business 100,
which celebrates leaders combining
profit and purpose to help achieve
the United Nations Global goals.
Global Winners under the Waste
Beneficiation category in the Global
CleanTech Innovation Program
conducted by United Nations
Industry Development Organization(UNIDO), CleanTech Global and
IDEMI.
Smart Bio Award for the Year 2019
for the outstanding contribution in
Bio-industrial Category, conferredby Department of IT, BT and S&TGoKNational Entrepreneurship Award
2019 Under Renewable Energy andWaste Management Category by
the Minister of Skill Development
and Entrepreneurship (MSDE).

www.aspartika.com
11

Startup Name

Product/Technology

ATATRI Design

Powered Air Purifying Respirator

Unique Selling Point: Biologically Targeted Active Purification Technology
Product Positioning: Medical Device, Military equipment.
National/Societal relevance: IIndigenisation makes it affordable and ensuring
healthcare workers safety.
Import Substitution: Yes

Present stage of Development
Market Testing
Geographical Region Targeted:
India Initially
Cost:
12,000/unit

Export Potential: Yes
Product Picture

Units sold:
12
IP Status:
Filed
Major Achievements(including awards):
NA

Contact details

12

Mobile No: : +91 9994930092

Emailragav@atatri.com

Websitewww.atatri.com

Startup Name

Product/Technology

Auflows CardioTech Pvt Ltd

Pulmonary Circulation Assist Implant

Unique Selling Point: The implant is a passive device and does not have any
battery-operated moving component hence it is maintenance-free.
Product Positioning: There is no product available in the market. The
competitors are working on various types of miniature pumps
National/Societal relevance: Children born with univentricular heart have notreatment available for preventing Fontan circulation and hence pulmonary
AV malformation
Import Substitution: NAs

Present stage of Development
The prototype has been designed
which needs to be constructed out of
hemocompatible (PTFE) material foranimal trials
Geographical Region Targeted:
India and other countries (global)
Cost:
NA

Export Potential: NA

Units sold:NA
IP Status:
Full specification submitted for the US
patent application
Major Achievements(including awards):
NA

Contact detailProf. S.D. Sharma
Mobile No: : +91 9769771238

Emailsd.sharma@iitb.ac.in

Websitewww.auflows.com

13

Startup Name

Product/Technology

Aumeesh Tech Pvt Ltd

MSO (Mechanically Stable Orthosis) KAFO

Present stage of Development
Pre-Commercialization

Unique Selling Point: Dynamic KAFO with advance feature at affordable price
Product Positioning: India’s First Mechanical Dynamic KAFO

Geographical Region Targeted:

National/Societal relevance: Over 16 million in India people suffer fromvarious locomotor disabilities. The present conventional KAFOs provide
stability during walking by locking the knee joint in a fully extended position
during both stance and swing phases. This results in excessive energy
consumption and induces abnormal gait events, limited mobility, pain, and adecreased range of motion ROM in lower limb joints. Due to the above factors,
the rejection rate of using KAFOs in patients with muscular weakness of thelower limb have been reported as being between 60 and 100.
MSO is a unique solution that addresses the basic need for locking andunlocking of the mechanism according to the stance of the user. It includes
force transmitters which provide an extra boost to straighten the leg as the
person walks. The solution –Orthotic brace is light weight, comfortable andintuitive to operate.
Import Substitution:mechanical joints)

ottobock , becker , drop-lock,(stance controlled

14

Cost:
20,000/- 49,000/- & 89,000/-

IP Status:
Filed, not published yet

Major Achievements(including awards):
y
y
y
y
y
y

Export Potential: Yes

Contact details

All over India and later international

Shahnaj
Mobile No: : +91 9990864336

WebsiteIITK – Techkriti
BIG Grant 14th Call
Big ideas summit award
NCPEDP – MPHASIS award
Infosys Social Innovation AarohanAward – Silver Category
News Nation Interview

www.aumeesh.com/

15

Startup Name

Product/Technology

Bagmo Private Limited

IoT based blood bag monitoring solution

Present stage of Development
Pre-commercialization (TRL - 7)

Unique Selling Point: No unsafe blood reaches the patient ; Increaseavailability and reduction in wastage ; Traceability & accountability ; Quality
Assurance & Hemovigilance
Product Positioning: Our solution monitors the storage conditions of bloodbags while it is transported and stored through RFID technology. Using oursolution we will be able to provide data regarding vein to vein that is fromdonor to patient along with end to end tracking and traceability that is madeavailable for Public and Private Hospitals to ensure safe and quality blood.

Geographical Region Targeted:
India and other developing countries

Cost:
Rs 75,000/- ( minimum 3 units required
per hospital)

National/Societal relevance: In India almost 70% of the population live inrural areas and availability of blood in rural areas is very low. Chances of dying
is one in 6 due to pregnancy related cases in the poorest part of the world
which are preventable. Our solution will increase the availability of blood andhence referrals can be reduced from community health centers and primary
health centers.

Units sold:30
IP Status:
Two Patents Applied

Major Achievements(including awards):

Import Substitution: Yes
Export Potential: Studies found that blood supply chain complexities indeveloping countries like : expiry time, temperature and transportation
requirements, supply and demand gap etc. Many low income countries stillpractice unbanked directed blood transfusion which can be avoided by having
effective blood supply chain monitoring solutions.

16

y
y

Product Picture

Contact detailsyAshfaq Ashraf
Mobile No: : +91 9961948748

WebsitePATH - selected as one of the 12
startups for improving primary
healthcare in LMIC.
Finalists in Qualcomm Design India
Challenge 2020
Nasscom t4g - Technology for good
- Finalists 2019www.bagmo.in

Startup Name

Product/Technology

BarifloLabs Pvt Ltd

Integrated Sediment Aeration System, Intelligent Monitoring System

Unique Selling Point: Cost effective, Intellectual Property
Product Positioning: for Urban and Rural municipal waterbody rejuvenation,
Aquafarming
National/Societal relevance: Relevance under this schemes & programs.
Green India Mission, Pradhan Mantri Jhanij Kheshtra Kalyan Yojana(PMKKKY) , Pradhan Mantri Krishi Shinchai Yojana (PMKSY), Pradhan
Mantri Matsya Sampad Yojana (PMMSY), National Action Program to
Combat Desertification, National Afforestation and Eco-Development,
Natural Resources Management, Rainfed Farming System, Horticulture,“Integrated Nutrient Management Sustainable agriculture , national Schemeon “Welfare of Fishermen” and “Development of Inland Fisheries” , Swachh
Bharat Mission, NPCA, National Mission on Pilgrimage Rejuvenation andSpiritual Augmentation Drive (PRASAD), Development of Inland Fisheries andAquaculture through NFDB scheme.
Export Potential: Very High
Product Picture

Contact details

Vicky Vikram Das
Mobile No: 8249058532

WebsitePresent stage of Development
TRL 7-8
Geographical Region Targeted
Odisha, Tamilnadu, Telengana,
Andhrapradesh, Maharashtra
Cost:
INR 250000

Units sold
15 Units
IP Status
22 Patents granted

Major Achievements(including awards):
MANAGE, NAARM, VIT TBI, T-HUB,
Ministry of Housing and urban Affairs

www.bariflolabs.com

17

Startup Name
BhoomiCam Private Limited

Product/Technology
Precision agriculture monitoring services using imaging sensors,
UAVs, and AI techniques

Unique Selling Point: They agricultural start-up aims to revolutionize theway farmers manage their crops by utilizing cutting-edge technology suchas artificial intelligence, drones, satellite remote sensing data, and crop yieldand health identification. By leveraging these tools, our goal is to increase
crop yields, reduce costs, and improve the overall efficiency of the agriculturalindustry.
Product Positioning: National/Societal relevance: This start-up serves as arepresentative for the AgriTech sector of the economy. Our fledgling businessis working to improve agricultural output in India by creating a service thatis reasonably priced, widely available, and simple to operate. They will tailor
AI and satellite based digital agricultural solutions to meet the specificrequirements of each individual farm. Using AI in conjunction with data fromsatellites and cameras, the major goal is to compile digital "health cards"
for each farm, which will include information on the farmers and their crops
quality on a seasonal basis. With the use of they android application, ourcompany's main purpose is to provide low-cost technology-based solutions
to farmers and connect with them private insurance and seed companies
along with government organizations and NGOs directly, with the end goal of
empowering those persons to make timely decisions on their farms, even if
they lack any prior scientific experience.
National/Societal relevance: In India almost 70% of the population live inrural areas and availability of blood in rural areas is very low. Chances of dying
is one in 6 due to pregnancy related cases in the poorest part of the world
which are preventable. Their solution will increase the availability of blood andhence referrals can be reduced from community health centers and primary
health centers.
Export Potential: To improve the technology further for commercialization,
the following steps can be taken
y Conduct more field trials to gather more data and test the technology
under different conditionsy Develop and integrate more advanced AI algorithms to improve theaccuracy and efficiency of the analysis
y Collaborate with other companies and organizations in the agricultureindustry to gain access to their data and expertisey Invest in R&D to improve the durability and reliability of the sensors and
UAVs used in the system
y Develop partnerships with farmers and other stakeholders in the
agriculture industry to gain insights into their needs and requirements

Contact details
18

Dr. Siddhartha Khare

WebsitePresent stage of Development
They are in the pre-seed STAGE (Early
stage, Pre-product) . They received asmall funding of 7 Lakh to develop a
prototype from TIDES Businessincubator of IIT Roorkee.
Geographical Region Targeted:
Entire India
Cost:
Not decided yet
Units sold:Not sold anything yet
IP Status:
Not applied yet
Major Achievements(including awards):
The prototype of my start-up won two
National award this year. Our idea has
been selected among top 3 ideas at
India's biggest Geospatial Geosmart
2022 conclave held at HICC Hyderabad.
They were selected for Bronze Award
Winner for I-CON Contest 2022 andreceived this award from former ISRO
chairman Dr. A.S. Kiran Kumar. Ourstart-up has won another competitionand secured first rank in AABTonics
National level Geospatial Competition
organized by leading GIS multinational
company AABSys IT. As a winning team,
we received Rs. 50000/- as a prize
money, and invitation to pitch in front ofinvestors.

www.bhoomicam.com

19

Startup Name
Biodimension Technology Pvt Ltd

Product/Technology“Lab-made human tissues” as an alternative testing
method to animal experiments
Present stage of Development
Testing & Validation stage

Unique Selling Point:
1.

Biodimension’s novel formulation and development process provides
faster tissue growth and maturation, thereby reducing the supply
time to customers and superior advantages in terms of uniform tissue
architecture and less batch variability. Also Biodimension brings in
product shipment at room temperature, which eliminates the cold chain
dependency to ship the tissue across the globe - a major supply chain
advantage.

Product Positioning: Human tissue models and methods are an alternative toanimal experiments, it will be supplied directly to customers (B2B), cosmetic
companies, and testing labs, they use tissue models for testing the safety
and toxicity. As per the regulations, Pharma companies procure their tissue
models for screening the drugs and testing their efficacy.
National/Societal relevance: Aligning with the global mission, ensuring the
lives of human and saving the animal lives with our improvised non-animal
testing on lab made human tissues.

Geographical Region Targeted:
Indian market
Cost:
Average - 10,000 INR/tissue (depends
on the surface area)
Units sold:
20 tissues are processed as a pre-orderfor customer validation
IP Status:
1 provisional patent for our formulationand 2 other patents are in-process offilingImport Substitution: 100% from France and the USA
Export Potential: The market available for non-animal alternative testing
was valued at $1.1 billion in 2019. The non-animal alternative testing market
is estimated to grow at a CAGR of 10.40% during 2019 – 2025. India is a
developing market and has a market size of USD 70 million (INR 560 Crore),
which is 100% import market. Europe and north America are the two major
markets for the non-animal testing, where US has $ 328 million market andEU has $ 300 million market size.

1.

2.
4.
7.
8.

Contact details
20

Ranjith Kumar Velusamy
Mobile No: 8973530955

Major Achievements(including awards):

Awarded grant-in-aid support from the
Department of Biotechnology (DBTBIRAC) under Biotechnology Ignition
Grant (BIG);
Letter of Intents from potential
customers; 15 customers in sales
pipeline
Tissue engineering R&D facility;
WinnerofAmbedkar
Youth
Entrepreneurship League 2022 by the
Ministry of Social Justice.
Part of 22 promising India deep-techstartups mentored by Atal Innovation
Mission under the PRIME program.

Emailranjith@biodimension.in

Websitewww.biodimension.in

Startup Name

Product/Technology

Biopioneer Pvt. Ltd

NexGen HM Protease Inhibitor: 1st Made in India protease Inhibitor

Unique Selling Point:
1.
It is a single material having multiple protease inhibition ability.
2.
It has strong efficiency to inhibit proteinase K.
3.
Stable at ambient temperature and even at high temperatures(95ºC).
4.
Compatible with different buffer conditions.
5.
Stable in a wide range of pH.
6.
Non Toxic
7.
Water-soluble
8.
EDTA Free9.
It is also 2-10 times less expensive.
Product Positioning: NexGen HM is a next generation protease inhibitorthat bridges the gaps that other protease inhibitors currently available in themarket consists. Our product is highly stable, non-toxic, thermally stable andmost importantly is very affordable. All these benefits that are being offeredby NexGen HM makes it a highly potential product to be positioned globally.
Being the first protease inhibitor being manufactured in India it also has agreat potential to replace other imported protease inhibitors in the market
National/Societal relevance: Today almost all the protease inhibitors being
used in laboratories across our nation are imported and none of them ismanufactured here. This system adds to the cost of the product and ultimately
affects the affordability of protein research. Therefore, to alleviate thisproblem Biopioneer pvt. ltd. came up with the NexGen HM protease inhibitor
which is the first made in India protease inhibitor and is almost ten times morecost effective than the existing protease inhibitors in the market. As India is
hub of protein-based vaccine production, and this newly developed proteaseinhibitor could be used as an ingredient during process of manufacturing. If
indigenous proteinase inhibitor is used in this sector, it could help to reducethe dependency on import.
Import Substitution: NexGen HM Protease Inhibitor has the potential tosubstitute the existing protease inhibitors being imported in our country as
our product fills the market gaps that these products have.
Export Potential: NexGen HM protease inhibitor is highly efficient and costeffective protease inhibitor consisting of several USPs making it a uniqueproduct globally. In addition thermal stability is an added advantage which
eliminates cold chain transport ultimately increasing export potential.

Present stage of Development
The product is market ready
Geographical Region Targeted:
As protease inhibitors are widely used inevery Biotech research facility, Vaccine,
enzyme, recombinant DNA protein
company, around the globe, so, initially
we are targeting to get our product inevery laboratory in India and eventuallysell the product globally

Cost:
15,108+ Tax /- for 15ml vial which is
50X concentrated

Units sold:30
IP Status:
Patent PublishedtyyyMajor Achievements(including awards):
Recognized among the top 20
biotech start-up in Odisha by
Government of Odisha.
Biopioneer has been recognizedamong the top 10 biotech start-ups
2021 by Industrial Outlook
NexGen HM protease inhibitor has
been highlighted by Contentwire
India, a reputed magazine entiteled
as An Emerging Next-gen Protease
Inhibitor Innovation Start-up

Product Picture

Contact detail

Mobile No: : +91 7991084428

EmailWebsiteinfo@biopioneer.in
www.biopioneer.in21

Product/Technology

Startup Name

Cerebo: A handheld device to detect asymptomatic intracranial
bleed non invasively within a minute

Bioscan Research Pvt. Ltd

Present stage of Development
Fully developed

Unique Selling Point: Rapid detection, Non invasive (no harmful radiation),
portable, Easy to learn and use
Product Positioning: Objective triaging of asymptomatic/mild TBI patients.
Best placed in Trauma centers, ER, ambulances, hospitals, clinics, defense,
sports etc.

Geographical Region Targeted:
GlobalNational/Societal relevance: Every minute in India, 3 people either die or
become disabled because of traumatic brain injury. If we diagnose thesecases, we can potentially save 180 lives per hour from dying or becoming
disabled for life.

US patent application: 1 granted, 2pending, Indian Patent: 2 granted, 3pending, PCT - 5, Design patent granted:
3, Trademarks Granted: 11

Import Substitution: Make-in-India product

Major Achievements(including awards):
Completed multicenter trial on morethan 590 subjects with more than 91
percent accuracy. Have won more than
30 national and international awards
including ASME ISHOW India 2020
Winner in healthcare, Best healthcare
startup of India by India Israel Innovation
Challenge 2018, Best Incubatee
company in healthcare by ISBA 2019,
BIRAC Ignite, Next Big Idea Canada, CIIInfosys Starpreneur award

Export Potential: High Globally.
Product Picture

Contact detailss

22

IP Status:

Emailanupam@bioscanresearch.com

Websitewww.bioscanresearch.com

Startup Name

Product/Technology

Blackfrog Technologies Pvt.Ltd

Emvolio - Portable Medical Grade Battery Operated Refrigerator

Present stage of Development
Ready for commercialisation

Unique Selling Point: Active cooling device with battery backup of 15+
hours, continuous temperature monitoring, location tracking, state-of-charge
indication

Geographical Region Targeted

Product Positioning: Health Centers, R&D Laboratories, Pharma & Diagnostic,
Eye Bank & Medical & Research InstituteNational/Societal relevance: Emvolio strictly maintains the pre-set
temperature for up to 12 hours which is used for transportation of vaccinesand other biologicals. Emvolio as a solar-powered battery-operated device
provides a critical health energy nexus much required in remote regions withintermittent power supply and can operate as a stand-alone refrigerator atlower power consumption.
Export Potential: Can be sold to all across the world as there is currently no
ready to market product available.

Rs.1,27,000 + GST = Rs.1,55,000/(MRP)

Cost:
500+ units, we are in 12+cities domestic& 3 Countries international level

Units sold
15 Units
IP Status
3 product patents and 7 design patents
1.

328026 : ‘Portable
Refrigerator’

Biomedical

2.

325697 : ‘Refrigeration device forregulating temperature of small
volume loads’

3.

363430 : ‘Computing device
for traceability and delivery ofpharmaceutical drugs to patients’.

Major Achievements(including awards):
1.

2.
3.
4.
5.
6.
7.
8.

Contact details

Mayur Shetty
Mobile No: 9916452021

WebsiteBengaluru Tech Summit Blackfrog
won the “Best product against
COVID-19”
NIDHI - Grant from DST, Govt. of
India
BIRAC- Biotechnology Ignition Grant
India Innovation Growth Programme
2.0
National Conference for Social
Innovation 2019
National
Bio-Entrepreneurship
Competition 2019- 3 awards
Qualcomm Design in India Challenge(QDIC-2020)
Confederation of Indian Industries(CII) Startupreneur awards 2020 :Blackfrog won the Forbes-Marshall
Manufacturing award.

www.blackfrog.in

23

Startup Name

Product/Technology

BoviEdge Research LLP

Small RNA based Early Pregnancy Detection Kit

Unique Selling Point: The product has the ability to pick up the pregnancy as
early as day 25 post artificial insemination. It has the efficiency to detect the
pregnancy even at the low concentration of miRNA. Since the result is seen
as a color change with naked eye, it excludes the use of expensive laboratory
equipment and expertise of handling the equipment. It is easy to use.
Product Positioning: A field friendly test kit with ability to detect pregnancy as
early as day 25 of AI in bovines – thus offering additional income generation
for farmers by increased lactation.
National/Societal relevance: It has been estimated that over 73 million
artificial inseminations are performed in bovine annually (NDDB). Also,
traditional pregnancy detection assays for livestock have a detection limit of
35-40 days post artificial insemination with poor sensitivity causing significant
economic loss to Indian farmers. Therefore, an early pregnancy detection kit
with an ability of detecting pregnancy as early as day 25 of AI, can be a gamechanger in India’s dairy industry with product revenue potential of > INR 1000
Cr Per Annum thus indicating promising future of the business.
Import Substitution: It is exclusively trying to produce the innovation with thematerial purchased from the companies established in India. In fact, BoviEdge
is synthesizing the nanoparticles using Neem leaves in our laboratory fordeveloping the chemistry of our productExport Potential: The target Market includes Small to Marginal Dairy Farmers(Millions in number); Medium Class; Rural; Primary to Middle class income
group including Livestock Farmers, Veterinary Doctors, Veterinary ResearchInstitutes, Livestock companies within the country.
Product Picture

Present stage of Development
The technology has been progressing
from TRL5 to TRL6 and is proven towork in a laboratory environment. We
are currently testing it on the blood
samples of pregnant animals collected
form National Dairy Research Institute.
Further, in order to test the sensitivity and specificity of the product, they
have cross validated the technology
based results with another laboratory
based detection method called Q-PCR
amplification. Based on the outcomes,
The LLP is now planning to test our
technology in the field samples inorder to gain the confidence on its
robustness
Geographical Region Targeted:
Haryana, Rajasthan, Uttar Pradesh,
Uttrakhand
Cost:
INR 100
Units sold:Not Applicable.
IP Status:
Application for Patent Filing is underpreparatory phase.

Major Achievements(including awards):
Recipient of Fulbright-Nehru Doctoral
Fellowship, Received first Prize atInternational Conference on Proteomics
for System Integrated Bio-Omics, One
Health and Food Safety for the discovery
of pregnancy related biomarker.Received
BIRAC-BIG Grant of INR 5 million in
support of technology development.
Attended WRCB summit on Next
Generation therapeutics at IIT- Bombay

Contact detail24

Dr. Parul Sarwalia
Mobile No: : +91 8901125661

Emailboviedgeresearch@gmail.com

Websitewww.boviedge.com

Product/Technology

Startup Name
Bramhansh Technologies Pvt Ltd

Migraelief- A drug-free wearable solution for instantaneous
migraine and tension headache pain relief
Present stage of Development
Product Developed, Clinical Trials areundergoing

Unique Selling Point: Clinically Proven Technology, Drug free
Product Positioning: Healthcare Medical Device
National/Societal relevance: Apart from serving the millions of patients
suffering from Migraine, Bramhansh is also helping women from rural India
with employment and upgrading their stitching skills which is final stage of
assembling our product. The plastic enclosure of the product is covered with
soft premium fabric which is specifically designed and stitched on the productwith the help of our partner women NGOs from Chhattisgarh. This helped toserve a huge national cause by empowering basic skills of women and helping
them run their households and send their children to schools.

Geographical Region Targeted:
Bangalore, Mumbai
Cost:
Rs 10000/-

Units sold:
40

Import Substitution: Currently only foreign products are available in market
and our product is completely “Make in India”.
Export Potential: More than 500 million individuals are diagnosed withchronic migraine pain globally. And only three major competitors are available
in the global market who are serving this market. The competitors in theforeign market are available at 2.5 times our price and have the same featuresand results. In the past 5 years, these 3 major players have served 0.1% of thetotal market globally and have generated a revenue of Rs 125 Crores.
Product Picture

IP Status:
Patent Granted, Patent No-355889

y
y
y
y
y
y

Contact details

Ashfaq Ashraf
Mobile No: : +91 7828881732

WebsiteMajor Achievements(including awards):a) Technology Patent Grantedb) Product Developedc) Pilot Efficacy Trials doned) Onboarded Hospitals and Clinics
for initial Salese)
Manufacturing
Certificates
Obtainedf) Revenue of Rs 3Lakhs Generated

www.bramhansh.com

25

Product/Technology

Startup Name

Farm animal nutraceuticals throughAccelerated Natural Biotransformation

Chem Life Innovations

Unique Selling Point: Productivity enhancing bioactive formulations withmaximized activity

Present stage of Development
TRL6

Product Positioning: Productivity enhancers

Geographical Region Targeted:
Domestic & South East Asia

National/Societal relevance: Value enhancement of herbs, agri by-products& wasteCost:
Rs. 105 per unit

Import Substitution: Essential Amino acids, Organic acids
Export Potential: As poultry, dairy & swine value added feed additives

Units sold:20000+

Product Picture

IP Status:
Patent appliedyyyContact detail

26

Email

innovate@chemlifeinnovations.com

Websitewww.chemlifeinnovations.com

Major Achievements(including awards):
Recognized as one among the top 5
finalists in Animal Husbandry Grand
Challenge, 2019
Winner at Regional Finals Hosted
byclimateLaunchpad,theentrepreneurship offering of EIT
Climate-KIC
Recognized as one among the top
75 entrepreneuers in India

27

28

29

Product/Technology

Startup NameHigh green value-added green products made from agri-crop
waste using circular fiber technology.

CrasteUnique Selling Point: Two Product Portfolios :a.

b.

Tree free packaging solutions: 1. 62.5% better in CO2e emissions, 2. 48.9
% cheaper as compared to virgin pulp - 3. Home compostable, 4. Food
Grade 5. Customizable according to clients’ requirements
Engineered Green Boards: 100% E0 Formaldehyde free, 2. 2x stronger
as compared to particle board, 3. moisture resistant (7x better water
absorption capacity than particle board), 4. versatile applications infurniture and construction domains

Product Positioning: The tree free packaging solutions are positioned tocompanies who are looking for sustainable packaging over plastic based/
tree-based packaging. The product will reach out to sustainable teams/CSO
of MNCs directly. We do look out for specific challenges proposed by thesecompanies and offer them packaging solutions. In the Engineered Green
Boards segment, our customers include furniture designers, architects, end
customers of furniture and construction applications.
National/Societal relevance: The startup aims to solve the issue of crop
burning and deforestation. Around 500 million Tonnes of crop residue isgenerated in India alone, out of which 90 MT is burnt on fields as crop stubble
waste. Crop burning releases around 150 million Tonnes of CO2 into theatmosphere, resulting in serious air pollution challenges in our cities. We solve
this issue by preventing crop burning, providing extra income for farmers,
generating rural employment and delivering eco-friendly packaging options
to consumers and societies.
Import Substitution: India is dependent on imports of virgin pulp and recycled
paper which has resulted in volatility and an acute shortage of pulp in the
Indian market leading to soaring prices. Furthermore, India imports timber
annually in large amount (> 450 billion INR in FY 2022), using crop waste as analternative will save precious foreign reserves in a volatile global world order
and will help towards building Aatmanirbhar Bharat.
Export Potential: They have worked with global MNCs and we have alreadysupplied sample products to international players in various countries.
The traction we have received so far, especially from ASEAN countries is
encouraging. We are planning to export our products in the next quarter.
Product Picture

Contact details

30

Email

shubham@craste.co

Websitehttps://craste.co/

Present stage of Development
Pilot stage (Our first factory is setting
up in Madhya Pradesh).
Geographical Region Targeted:
PAN India
Cost:
Depends on the products and customer
requirements.

Units sold:
Different units sold in different SKU
categories.

IP Status:
Patent pending on our circular fiber
technology.

Major Achievements(including awards):
Social Innovation Immersion Programme
Fellowship – May 2017, Top 500
Global Startups - Hello Tomorrow– October 2017, AIT Swissnex India
Finalist – November 2017, Runner
up Ipreneur - Tata Institute of Social
Sciences – December 2017, BIRAC
SOCH Award – March 2018, Winner- National Conference on Social
Innovation – November 2018, Stanley
Techstars Accelerator – June 2019,
Biotech Ignition Grant – June 2019,
Millennium Alliance Award – July 2020,
Sustainability leaders in the world- Sustainability Awards 2021, 100+
Remote Accelerator ProgramStartup Name
Cuor Stem Cellutions Pvt Ltd

Product/Technology
Easy testing for drug for Alzheimer's disease using humanstem cell derived disease model

Unique Selling Point: The technology uses human stem cells in which theread out time is 1/10th of the time that is used by other technologies. Our
technology is developed as an accurate alternate to animal testing.
Product Positioning: We develop highly predictive human disease model
assay systems for efficacy testing aiming to accelerate drug candidate
selection, reduce costs and ultimately increase drug discovery & development
efficiency. Our technology is developed as an accurate alternate to animal
testing. Drug testing without the use of animals has been recently approved
FDA and we believe our product is positioned well to flourish in this enormous
marketNational/Societal relevance: We believe that stem cell technology fast-tracks
the delivery of better medicines to patients by improving the drug discovery
process in age related diseases such as Alzheimer’s disease. We develop highly
predictive human disease model assay systems for efficacy testing aiming
to accelerate drug candidate selection, reduce costs and ultimately increase
drug discovery & development efficiency. This is especially relevant in India
from where no new effective drugs for Alzheimer’s have yet been discovered.
Import Substitution: Our technologies can replace animal models of
Alzheimer’s disease which has been developed outside India
Export Potential: The drug testing services platform can be marketed to drug
manufacturers to test their drugs in-house.

Present stage of Development
Technology has been developed, beta
tested and patent obtained
Geographical Region Targeted:
India, Europe, USA, Australia, Singapore

Cost:
USD 3000 per drug testing

Units sold:
10 units
IP Status:
Complete specification of the patent has
been obtained in Indiayyy

Major Achievements(including awards):
Selected among the 75 Women
Entrepreneurs in 2022
Used the testing platform forservices in India and Australia
Patent granted in India

Product Picture

Contact detail

Dr Sudha Warrier
Mobile No: : +91 9731218409

Emailsudhawarrier@cuorstem.com

Websitewww.cuorstemcellutions.com

31

Startup Name
Cutting Edge Medical Devices Pvt. Ltd.

Product/Technology
SCINTIGLO – A smart point-of-care urinary micro-albumin /micro-protein estimation device.

Unique Selling Point: Instant, Non-Dipstick based, Quantitative, Stablereagent, with long shelf life without refrigeration, Extremely easy to use &portable device, Data Storage & Telemedicine ready
Product Positioning: The Private healthcare market – small & medium size
pathology labs, Clinics & Hospitals.
Public Healthcare organizations.

State governments and NGOs and Philanthropic

1.

The device will be extremely useful for the National Maternal & Child
Health Program

2.

The Non Communicable diseases control program3.

Pradhanmantri Free dialysis program.

Export Potential: Enormous, to developed and developing countries alike.
Product Picture32

Device – Offered a Device as a Service &Consumables @ Rs. 150/test

Units sold:10000 units of consumables

Import Substitution: Yes, and in addition to this it is a novel device solving a
global need.

Mobile No: : +91 9873275305

Geographical Region Targeted:
Initially India. Later it to Africa & other
Developing countries and to developed
countries for home healthcare

Cost:

National/Societal relevance:

Contact details

Present stage of Development
TRL – 9 – Product already in themarket.

IP Status:
Patent filed & Pending – 2278/
MUM/2015

Major Achievements(including awards):
30 National & International Awards
and Also featured on Shark Tank India
Season 1

Emailinfo@cemd.in

Websitehttps://cemd.in

33

34

Startup Name

Product/Technology

Duosis Bio-Innovations Pvt Ltd

Jellnex

Unique Selling Point: Utilisation of tamarind seeds as a novel, cost-effective& sustainable source of potential bio-polymer “Jellnex”

Present stage of Development
We have developed MVP of our
product

National/Societal relevance: We envisage giving employment to local
community and tribes with our work.

Geographical Region Targeted:
Jharkhand

Import Substitution: Yes
Export Potential: Yes

Cost:
500rs/kg

Product Picture

Units sold:30
IP Status:
Trade Mark filed

y
y
y
y
y

Contact detail

Mobile No: : +91 7992499157

WebsiteMajor Achievements(including awards):
NIDHI-EIR Fellowship
BIRAC-Biotechnology Ignition Grant
Atal Bihari Vajpayee Innovation Lab(Start-up Jharkhand funding)
BIRAC-TiE WInER AwardMCX CSR Fund

www.duosisbio@gmail.com

35

Startup Name

Product/Technology

Earthtech Innovations Pvt Ltd.

Smart Biogas Plant with AI and IoT for Best Efficiency

Unique Selling Point: Modular and scalable design, Fully Automated Plant.
Requires 30% to 50% less space. Consumes 80% less water. Up to 60% more
efficient due to IoT and AI Technology. All season stable and boosted gas
output. Committed to safety.
National/Societal relevance: There will be a huge reduction of methane 25X
potent greenhouse gas directly to the atmosphere due to OFMSW dumping
as all this waste will be converted to green and efficient fuel. Moreover, thereduction of transport costs of waste to dump sites that are far away fromthe city will save fuel and money. The technology proposed can replace fossil
fuel-based LPG and coal-based electricity at a meaningful scale to be a viableurban fuel source. Doing so provide ready-to-use and organically rich andready to-use fertilizers.
Export Potential: Technology has a huge potential. Can be exported to any
tropical country that wants to rely on organic farming as well as sustainableclean cooking. The innovation has a very wide scope of industrial applications.
Primarily it can be used anywhere where the organic waste is generated.
Also, it can be used in ceramic industries, dairy industries, and in industries
where all this process takes place waste treatment and incineration, metals
preheating particularly for iron and steel , drying and dehumidification, glass
melting, food processing, and fueling industrial boilers, etc. The Scope oforganic fertilizer in form of slurry has various applications.

Present stage of Development
Pre-commercialization
Geographical Region Targeted:
Pan-India
Cost:
2500000 for 1TPD plant

Units sold:
Pre-Order received from customers

IP Status:
The IP is generated in form of a patent.
Moreover, through this project, somenew IPs will be filed in form of Industrial
Design, and Patent within nearby future.

Major Achievements(including awards):
WINNER of BIRAC-SoCH Challenge
2021. Supported by BIRAC & Social
Alpha

Product Picture

Contact details

36

Mobile No: : +91 9429442569,
7990726622

Websitewww.earthtechrenewables.com

Startup Name

Product/Technology

Embright Infotech Private Limited

AUTICARE – Immersive Tech and HCI

Unique Selling Point: AT based Inclusive Learning platform for Learning
Disabilities and Autism.

Present stage of Development
Ver 1.0 is commercialized.
And Ver 2.0 is in TRL7

Product Positioning: Auticare uses Immersive tech.
National/Societal relevance: Inclusive Learning Platform for Learning
Disabilities.

Geographical Region Targeted:
Pan India

Import Substitution: Auticare Ver 2.0 uses Eye tracking and BCI sensor inhouse developed.

Cost:
15 Units

Export Potential: The Product support multilingual- Middle East, Europe,
Canada and US.

Units sold:30

Product Picture

IP Status:
Two Patents Applied

y
y
y
y

Contact details

Mobile No: : +91 8792975982

WebsiteMajor Achievements(including awards):
2019 Best start up award by TMA &ADANI Group
2020- BIRAC by Department of
Science & Technology, Government
India.
2021-Emplanelled in GEM Portal by
Government of India.
2021- Finalist in Gitex Supernova
Challenge, Dubai

www.embrightinfotech.com

37

Startup Name

Product/Technology

Ensect Farm Pvt Ltd

IoT based blood bag monitoring solution

Present stage of Development
TRL 7

Unique Selling Point: Efficient Waste management - High mass volume
reduction (50-90%) in 10-12 days, Low GHG emission Alternative Protein:
Sustainable, Nutritional properties match fishmeal, Highly Palatable

Geographical Region Targeted:
South India, Pan India

Product Positioning:
Waste Management - B2G;

Cost:
Rs. 120 per Kg

Alternative protein -B2B & B2C (Poultry, Aqua & Pet food)Units sold:National/Societal relevance: Efficient technology for waste management &sustainable protein for the feed industry.

500 Kg produced for trial run

IP Status:
NA

Import Substitution: Soymeal, Krill Meal, Palm Oil & Fish meal
Export Potential: Yes - Sustainable Alternative Protein - Insect protein
Product Picture
y
y
y
y
y

Contact detail38

Anup TV
Mobile No: : +91 9894408020

Major Achievements(including awards):
India's First PPP Model showcasing
Entomo Composting - Vellore,
Tamilnadu
BIRAC BIGBIRAC SEEDDST Nidhi Prayas
Carbon Zero Challenge -IIT Madras

Emailanuptv@ymail.com

Websitewww.ensectfarm.com

Startup Name

Product/Technology

Epanipurii kartz

Automatic Dispenser IoT based with E-Nose Application

Present stage of Development
Prototype

Unique Selling Point: Remote operating by Mobile App
Product Positioning: Food Vendors

Geographical Region Targeted
GlobalNational/Societal relevance: Automation of Street Food Vendors
Import Substitution: Yes

Cost:
7-8 k

Export Potential: Yes

IP Status
Patent under process

Major Achievements(including awards):
BIG Grant & Design Innovation

Contact details

Harish Neotia
Mobile No: 7366904004

EmailWebsiteceo@epanipuricart.com
www.epanipuricart.com

39

Startup Name
Epygen Biotech PVT LTD

Product/Technology
Development of Receptor Binding Protein (RBD) antigen based advanced
Vaccine candidate against SARS-CoV-2 Variants

Present stage of Development
Pre-Clinical and clinical Trials level

Unique Selling Point: When compared to other vaccine host cells like theinsect (Baculovirus) cells, yeast cells or the Mammalian Cell lines (CHO Cells),
the C1 platform demonstrated several times greater productivity in antigen
expression levels and showed safety, efficacy, and potency. Additionally,
the C1-cells impart much closer to human glycan forms onto the RBD thanyeast cells which are hyper glycosylated. The plug and play host design torapidly express antigen against variants like OMICRON, unprecedented highexpression levels and simple process requirements offer a perfect solution tofight a virus that causes pandemic and mutates aggressively.

India & Indian Subcontinent, Sri Lanka,
Bangladesh, Nepal, Bhutan.

Product Positioning: The project is aimed to develop & quickly express
antigens against pandemic causing Viruses, utilizing the unique expression
host and drastically reduce production costs and ensure that the vaccines beaffordable and available in hundreds of millions dosages to the masses.

Under Development

National/Societal relevance: The accelerated development of RBD antigen
vaccines from high yielding C1 expression system will benefit the national andglobal initiative of mass vaccination at an affordable cost. The Platform allows
quick cloning of Covid Variant RBD and produces Variant Vaccine timely. The
project is aimed to drastically reduce production costs and ensure that thevaccine be affordable and available in hundreds of millions dosages required
to enable rapid delivery into clinical development and mass vaccination.
Import Substitution: When compared to imported vaccines and technologies
using hosts like the insect (Baculovirus) cells, yeast cells or the Mammalian
Cell lines (CHO Cells), this platform demonstrates several times greater
productivity in antigen expression levels and showed safety, efficacy, andpotency

Geographical Region Targeted:

Cost:
Target Price is INR 150

Units sold:
IP Status:
Patent of C1 Expression Technology
belongs to Dyadic International INC. USA
has been licensed to Epygen Biotech
PVT LTD for expression and productionof COVID Vaccine. Epygen Biotech India
has the full rights to the EpyCoV Covid
Variant Vaccine, a multivalent vaccine
against Omicon.

yExport Potential: This vaccine will be suitable for exports to semi regulated
and regulated markets of South Asia, Africa and Latin America due to the
expected low cost of this vaccine. Limited Clinical trials may be required forsome regulated markets.
yyContact details

40

Rishi

Email
WebsiteMajor Achievements(including awards):
Received
BIRAC
grant
to
manufacture C 1- RBD Vaccine
and conduct clinical trials Phase I
and Phase II after evaluation andrecognition of the potential of thistechnology for quick developmentof RBD vaccine against SARS- CoV2 Variants.
International news coverage of
Epygen Vaccine Technology with
BIRAC support in Bloomberg, Yahoo
Finance and Global Wire.
The potential of Epygen vaccine
technology received coverage by
all major Indian media houses e.g.
TOI, The Business Standard, The
Outlook, The Week, CNBC TV18 etc.

rishi@epygen.com
www.epygenbiotech.com

41

Startup Name

Product/Technology

Farm Gulp Pvt. Ltd.

Polyphenols: Catechin family of antioxidantsEpigallocatechin, Epicatechin, EGCG, Syringic Acid
Alkaloids: Arecoline, Arecaidine, Guvacine

Unique Selling Point: Areca Polyphenols which has application in various
Industries and areca alkaloids which has a potential API used in the treatmentof alzheimers and other CNS related disorders which is naturally available
only in the Areca.

Present stage of Development
Proof of Concept established andProcess Validation & Scaleup
Geographical Region Targeted:
Domestic market as well asinternational market

Polyphenols: Low value high Volume
Alkaloids: High value low volume
National/Societal relevance: Reduce the dependency of import of suchmolecules and support the indigenous startup exploring alternate natural
sources and innovative separation process

Cost:
INR 4000 to 5000 per Kg of
Polyphenols with 90% Catechin

Import Substitution: Green tea polyphenols, Green tea catechins. Thesemolecules have been imported by various countries from China.
Export Potential: Areca Polyphenols, Arecoline, Caffeine free EGC and EGCG
polyphenols. These molecules are novel and have a great export potential.
Product Picture

Units sold:
Product samples given for trials invarious industries
IP Status:
Complete Specification: 202041044653
submitted on 14th Jan 2022 forthe process patent. WIPO PCT: PCT/
IB2022/050287 submitted
on 14th Jan 2022.

y
y
y

y

Contact details

42

Nagendra Prakash
Mobile No: : +91 7795618099

Major Achievements(including awards):
Winner of Unnati prize money of
15L under the categoryofsocialinnovationfrom
Department of Social welfare,
Government of Karnataka.
One of the 12 startups selected for
the Karnataka startup advancement
programme(KSAP
BIO-50)conducted by C-CAMP along with
the Government of Karnataka.
Won 15 Lakhs from the MSME Idea
hackathon, monitored by Bangalore
Bioinnovation Centre with theGovernment of India.

Emailnagendra@farmgulp.com

Websitewww.farmgulp.com

Product/Technology

Startup Name
Fermentech Labs Pvt. Ltd

High titer industrial enzymes, prebiotics and high calorificvalue fuel pellet using Solid State Fermentation Technology
Present stage of Development
TRL-6/7

Unique Selling Point: Complete valorization of agricultural as well as industrial
wastes to produce value added products (Enzymes, Prebiotics, Simple sugars
and high CV fuel pellets) from a single process.

Geographical Region Targeted:
Pan India

Product Positioning: Low cost, high titer industrial enzymes and prebiotics
while addressing waste disposal issues of textile/food & beverage/animal
feed industries.

Cost:
INR 1500-4000 per litre of enzyme

National/Societal relevance: Since the agro-wastes are procured directlyfrom farmers, this adds to their income which is directly aligned with H’ble
PM vision of doubling the farmers income. They have procured more than
~20 tonnes of agricultural waste as of Dec, 2022 which otherwise would havebeen burnt and this has also resulted in additional revenue of ~6000 INR to
28 farmer households.

Units sold:~20 units worth 60K INR supplied tocustomers.

IP Status:
A novel SSF bioreactor (patent fileno. 201611020038), A process for
production of Xylanase, XoS and HighCV fuel pellets from a novel isolate A.
corrugatus (in process)

Import Substitution: Since most of the enzymes are presently imported inIndia, the present innovation presents a viable alternative to imports.
Export Potential: The global enzyme market is valued 7bn $ and is growing
at 7% pa. Further, with industries adopting sustainable practices for biomass
treatment and in order to cut carbon emissions, there is a huge potential forexports as well.
Product Picture

y

y

y
y

y
y

Contact detail

Mobile No: : +91 7409488318

WebsiteMajor Achievements(including awards):
Won
TechtonicInnovations
towards Zero Food waste challengeof DBS Bank and social alpha, Aug
2022.
Awarded Best Young Innovative
Entrepreneur award, at the Assam
Biotech conclave 2022 organised
by Guwahati Biotech Park and IIT
Guwahati, June 2022.
Awarded Best Startup Stall at TREX
Startup conclave 2022, organised
by IISER Mohali, October 2022.
Selected as the Winner of the AgLive
2022- Innovators Pitch competition
organised by CII-Food & Agriculture
Centre of Excellence (FACE) 5th Nov,
Chandigarh.
Finalists in Qualcomm Design India
Challenge 2020
Nasscom t4g - Technology for good
- Finalists 2019www.fermentechlabs.com

43

Startup Name

Product/Technology

FIBROHEAL WOUNDCARE PVT LTD

SILK PROTEIN BASED WOUND MANAGEMENT SOLUTION

Unique Selling Point: Faster wound closure, higher cell attachment, reduced
scar formation, cost effective

Present stage of Development
EARLY COMMERCIALISATION

Product Positioning: Comprehensive advanced & active Wound Management
Solutions using silk proteins.

Geographical Region Targeted:
INDIA & WORLDNational/Societal relevance: Import Substitution, cost effective productrange with ability to impact many lives including economic multiplier impact.

Rs 40 – Rs 4000

Cost:

Import Substitution: Yes

Units sold:
Upwards of 1 Lakh units

Export Potential: Yes

IP Status:

Product Picture

4 patents in hand

Major Achievements(including awards):
Winner of National Technology award
under start up category, winner ofStartup of the year during Bengaluru
Tech summit 2020 and finalist of
National Startup award in 2020.

D-FIBROHEAL – SUTUREDRESS (Silk protein
based adhesive dressing For post operative wounds

D-FIBROHEAL –Ag Powder ( Silk protein based
powdered dressing For different types of

D-FIBROHEAL – Foam (Silk protein based dressing
For high exudating wounds)

Contact detail

44

VIVEK MISHRA

EmailWebsitewww.fibroheal.com

Startup Name

Product/Technology

Flic Farm Pvt Ltd (XMachines)

X100 UGV (Autonomous Agricultural Robot for Dry Crops)

Present stage of Development
Product ready for sale

X100 UGV is a fully electric, Multi-purpose Autonomous Robot designed toperform agricultural operations that occur post plowing till pre-harvesting.
X100 UGV is autonomous and functions like a micro-tractor to perform
Seeding, Weeding, Spraying & Fertilizer Micro-dosing activities with the helpof various AI driven smart attachments.

Geographical Region Targeted:
No geographical limitations
Cost:
Starts from INR 1.75L

Unique Selling Point: The USP of X100 UGV is "Precision agriculture deliveredat an affordable price leading to productivity increase, cost savings &lowered crop inputs for Indian Farmer benefitting Indian Farmer, Consumer& Environment".

Units sold:2

Product Positioning: Vegetable growers in Polyhouses or outdoor farms. As
well as any dry crop farmer.

IP Status:
Patents Applied

National/Societal relevance:
1) There are no existing robots in the market at our price point of 1.75L, thus
making the product a cost-effective, efficient and portable solution even forheavy duty agriculture and industrial work.

y2) Bringing in a Rental Model via rural micro-entrepreneurs facilitates costeffective solutions for local farmers as well as revenue generating self
employment opportunities for the rural youth.

y3) As a Agri-based Company, we wish to encourage the youth to take up
agirculture as an active profession.

y4) By creating a chemical-free alternative way of addressing farming problems
we are shifting the perspective of farmers.

yImport Substitution: Yes
Export Potential: The product can be exported to Europe, Japan, Turkey,
Vietnam, Indonesia, Philippines, South Korea and many more industries.
We have already successfully commercially exported a Robot to a European
Customer.
Product Picture

Contact details

Mobile No: : 7674901046

yy

Major Achievements(including awards):
Successfully exported a robot to a
European Customer.
Selected into Food Tech 500 list 2021
Selected as one of 75 startups in 75
years of independence by BIRAC
Successfully finished pilot run with
Telangana State Agri University in 2
seasons.
Securedinvestment
interest
from one of the top agri input
conglomerates and in final talks.
We have also been invited todemonstrate our product andtechnology to various international
visitors for its merit. Some ofthose include visitors from World
Economic Forum, Researchers from
University of Copenhagen, British
High Commission and many morehigh profile visitors.

Emailtrivikramkumar@xmachines.ai

Websitewww.xmachines.ai/smart-farming45

Startup Name
FOOTPRO SOLUTIONS PVT LTD
Product/Technology: Podiatry or Foot related science is the key action areaof FootPro® . Every foot is unique and they need customised solutions to get
the maximum relief and benefits. We offer advanced foot care solutions bymeans of customised insoles & footwear to our customers through a unique
CAD-CAM technology, imported from Germany. The system consists of a 3D
Laser Scanner, a 3D designing software (CAD) and an automatic CNC millingmachine (CAM).
Unique Selling Point: 100% customization of Insoles using CAD CAM
technology combined with a 3D Laser Scanner
Product Positioning: Offering foot care services to people with diabetic andorthopedic foot related problems through customised Insoles and Footwear
National/Societal relevance: Foot care concept in India is at its earlier stage
only. People (mainly economically backward) are unaware or ignorant about
the importance of foot care and thereby ended up with disastrous results(amputation, permanent deformity and so on). A diabetic foot if not taken carewell, can cause the life of a person (& their family members too) miserable.
Import Substitution: Developed the raw materials for the Insoles (EVA)
indigenously. Under the process of developing an independent CAD CAM
system which is combined with a 3D Laser Scanner
Export Potential: A huge world market is open for this project as still thetechnology is in the hands of Developed nations and is costly too.
Product Picture

Contact detail

46

HARI G NAIR
Mobile No: : +91 9447011012

WebsitePresent stage of Development
9+ years of trusted service, 10 scanning centers and 40,000+ satisfied
customers. Expanding to other partsof India with more and more service
centers. Annual turn over of INR 2.7
Crore
Geographical Region Targeted:
All India
Cost:
INR 5000 approx
Units sold:
40,000+ pairs
IP Status:
Not applicable as the technology isalready exists in the developed countries
since many years
Major Achievements(including awards):
A data base of 40,000+ satisfied
customers, presence in 8 south Indian
cities and a trusted relation with the
medical fraternity through dedicatedserviceswww.footpro.inStartup NameFoundation for Neglected
Disease Research (FNDR)

Product/Technology
A Device to Deplete Antibiotic Residues from Wastewater toCounteract Anti-microbial

Unique Selling Point: Hospitals, Pharma industries, Animal husbandries,
Residential and Commercial complexes
Product Positioning: General public, private, and government complexes.
National/Societal relevance: To act against antimicrobial resistance.
Import Substitution: Filtration device

Present stage of Development
Technology Readiness Level-6
Geographical Region Targeted:
India and Outside India
IP Status:
Application under progress

Product Picture

Major Achievements(including awards):
Lab scale performance and deployed
in a hospital and proven the depletionof antibiotics. Other than antibiotics,
device is capable to deplete textile dyes,
pathogens, fluoride, heavy metals, etc.,

Filter Bag

Filter bag housing

Installation at Hospital STP

Contact detail

Dr. Shridhar Narayanan
Mobile No: : +91 9611598805

Emailshridhar.narayanan@fndr.in

Websitewww.fndr.in47

Startup Name

Product/Technology

Foundry Medical Technologies Pvt Ltd“SWASA” Ventilator

Unique Selling Point: Indigenously developed portable ventilator for
emergency ambulatory situations, providing a battery back-up of up to 4
hours continuously.
Product Positioning:B2G, B2B, B2C, NGO. They intend to take it toInternational markets and eventually seek FDA.
National/Societal relevance: There have been many instances where patients
have lost their life during transit to hospitals due to lack of proper ventilator
facilities in ambulances, especially during COVID. SWASA is a portable ventilator
that is easy to port from ambulances to ICU and can provide treatment during
the crucial time of travel to the hospital and within the hospital. The samedevice can be configured for both Paediatrics and Adults. Most ICU ventilators
are compressor based and hard to move, SWASA is blower based and easy
to carry. It has an additional monitoring unit that puts data into the cloud forremote monitoring.
Import Substitution: Before COVID, India had only about 16,000 Ventilatorsof which 90% were imported, which shot up to 36,433 in less than a year
because of the Global pandemic. Our Indigenously developed portable
Ventilator will provide self-reliance for a crucial product and protect against
global supply chain issues

Present stage of Development
Validation Stage
Geographical Region Targeted:
USA, European Union & Asia pacificcountries
Cost:
INR 6,00,000
Units sold:None as on date
IP Status:
IP filing is in process
Major Achievements(including awards):
3rd place in Global Ventilator Challenge

Export Potential: The global ventilator market size was USD 2.54 billion in2019 and is projected to reach USD 9.13 billion by 2027, exhibiting a CAGR
of 5.0% during the forecast period. Our device will be a competitor for the
Chinese Ventilators being deployed in the country. Provided the right support,
it can create an export potential to the under developing countries or countries
which require the emergency devices.
Product Picture

Contact details

48

Sai Praveen Panchakarla
Mobile No: : +91 9553585434

Websitewww.foundrym.inStartup Name

Product/Technology

Galanto Innovations Pvt Ltd

Smart Hand Rehabilitation System (RehabRelive Smart Glove)

Present stage of Development
Validation

Unique Selling Point: Faster recovery of hand movements, Virtual exercises
based on activities of daily life, Accurate assessment and tracking of recovery
progress, Lightweight and wireless device, Remote doctor consultation
Product Positioning: Virtual hand physiotherapy for faster recovery.
National/Societal relevance: Post-stroke disability is becoming alarmingly
common in the working population. Patients become overly dependent on
caregivers and cannot work leading to financial crises, isolation, and depression.
Current hand rehabilitation techniques are ineffective in enabling the patientsto recover effectively and reclaim their socio-economic independence.
Import Substitution: Yes (for FlintRehab, Anika and other virtual rehab
solutions)Geographical Region Targeted:
Pan India ( patients with hand disability),
Physiotherapy centers and Hospitals

Cost:
Multi account variant: Rs 1,00,000 (for Hospitals, Physiotherapy Centers);
Single account variant: Rs 35,000 (forindividuals)

Units sold:
30

Export Potential: Yes ( Target Market: Asia, US, Europe).

IP Status:
Filed

Product Picture

1.
2.
3.

4.

5.

6.
7.

Contact details

Dr Chandan Kumar Jha
Mobile No: : +91 7898392155

Email
WebsiteMajor Achievements(including awards):
Entrepreneur-in-Residence (EIR),TIH Foundation, IIT Bombay, 2022
Encouragement Award, Pitch-Fest,CAHOTECH 2022, Sep 24, 2022
Gandhian Young TechnologicalInnovation Appreciation Award(SITARE-GYTI)
2021,
BIRAC,
Department of Biotechnology, Govt.
of India
INAE
Young
Innovator
andEntrepreneur
Award,
IndianNational Academy of Engineering,Oct 10, 2021.
Gold medal, Outstanding Innovation
Award,
IndianInstituteofTechnology Gandhinagar, Aug 29,
2021
NIDHI PRAYAS GRANT, Departmentof Science and Technology, Feb
2021.
BIRAC cash prize,
National Bio
Entrepreneurship
Competition(NBEC 2020), Ministry of Science,
Govt. of India, Dec 2020

info@galantoindia.com
www.galantoindia.com
49

50

Startup Name

Product/Technology

Generation Net Nutrition Private Limited

Cordyceps militaris Mycelium Mat Tea

Unique Selling Point: Affordable price, vegan, gluten free, Cordycepin
1.96 mg/g, adenosine 0.54 mg/g, less production cycle, spill of products(natural yellow colour, cordyceps tablet, extract, power, ingredients for foodformulation), alternative protein sources with medicinal properties.
Product Positioning:
National/Societal relevance: The problem for lack cheaper Cordyceps
militaris products. The existing process is time consuming, collection fromwild, uncontrolled environments, identification issues, seasonal, not available
through the year etc. Our solution provides alternative approach where
mycelium mat is produced in controlled conditions. The mycelium-based
health medicinal mushroom product is available in China, Korea and othercountries. The products are developed using vegan ingredient, affordable
price Rs 10 to 30 per cup of Tea (1 gram of dry product).

Present stage of Development
Product production trials in Lab
completed.
Geographical Region Targeted:
India and Asia countries
Cost:
Rs 10 to 30 per gram

IP Status:
Under provisional patent

Import Substitution: Product coming from China and USA
Export Potential: Yes.
Product Picture

Contact details

Dr. Thiyam General
Mobile No: : +91 8449494640

Email
WebsiteFarden010@gmail.com
https://gnetn.com/

51

Startup Name
Genomiki Solutions Private Limited

Product/Technology
Bioinformatics Pipelines to analyse, interpret andreport clinical genomics datasets

Unique Selling Point: The product is a genome-informatics platform and/or service which will analyse complicated, high-throughput big biologicaldatasets in a very reasonable amount of time, will be affordable and promisehigh sensitivity and specificity. The innovative component of solutions will be
the use of genetic diversity of Indian populations.
Product Positioning: The solutions and services will empower diagnostic labs
to conduct the genomic tests at large scale with reduced costs.
National/Societal relevance: We are providing results in very short turnaround time and are very affordable which helps to reduce the economic
burden of the society and the nation
Import Substitution: The current market is using a lot of solutions not madein India. Yes, we are trying to build a product to substitute them.
Export Potential: The bioinformatics pipelines and algorithms developed
can be used to analyse datasets across the world. They are also building inhouse resources which are region specific especially India-specific and will be
gradually expanding them to cover other countries as well.
Product Picture

Present stage of Development
They have developed the bioinformatics pipelines for three genomic testingdatasets and have been validating
the efficacy with tie-ups with certain
diagnostic labs. They have also commercially provided these services forone of these pipelines.
Geographical Region Targeted:
We are targeting diagnostic labs
Pan-India
Cost:
Under Process

Units sold:
Under Process

IP Status:
Are going to apply

Major Achievements(including awards):
They have received a grant of INR
10,00,00 from Startup India Seed Fund.
They have been selected among top 20
and top 100 ventures at Women Startup
Program 3 at NSRCEL at IIM Bangalore

Contact details

52

Mobile No: : +91 9911554304

Emaildeeksha.bhartiya@genomiki.com

Websitehttp://genomiki.com/

Startup Name

Product/Technology

Godaam Innovations Pvt. Ltd.

Godaam sense-an IOT-based sensor

Godaam sense-an IOT-based sensor hardware product that uses industrialgraded sensors to collect real-time data from the field and analyze it at theback end using machine learning algorithms and communicating it with
farmers over text alerts
Unique Selling Point: Onion rotting detection
Product Positioning: N/A
National/Societal relevance: India is the second largest onion-producing
country i.e., 3 crores MT onions every year, where 70% of the production isstored in warehouses for a period of 6-8 months. Every year there is around40-50% wastage in the warehouses due to various reasons such as the mixed
variety sown, cultural practices followed and micro-climate conditions inwhich the crop is grown and stored
Import Substitution: No import substitution right now
Export Potential:
countries

Can be exported to the onion-producing and storing

Product Picture

Contact detail

Mobile No: : +91 7020785546

Present stage of Development
Ready to launch
Geographical Region Targeted:
Maharashtra, Madhya Pradesh,
Karnataka
Cost:
INR 11,000 /-Units sold:500+ devices

IP Status:
GrantedMajor Achievements(including awards):
Innovative women Agri entrepreneur
award - Krishithon, Business andinnovations award - Lokmat Sakhi,
Research published through an
International Conference, Women In
Agriculture award, People's choice award
Cleantech Global Idea Competition

Email
Websitewww.godaaminnovations.com

53

Product/Technology

Startup Name
Health Sensei India Pvt Ltd.

ICU Remote Monitoring

Unique Selling Point: Multibrand Monitor Compatible
National/Societal relevance: Allows remote monitoring by ICU doctors fromoutside the hospital also allowing crticial monitoring 24 hours.
Export Potential: Possible with certifications.

Present stage of Development
Commercial Scaling
Geographical Region Targeted:
Pan India
Cost:
Annual Subscription Model INR 1,00,000
for 10 monitors to be montiored

Units sold:
11
Major Achievements(including awards):
FICCI Award for partner hospital,
Commercial status within 11 hospitals,

Contact details

54

Dr Magitha Shyamsundar

Websitewww.healthsensei.co.inStartup Name

Product/Technology

HELO HEALTH TM
Adarsa Private Limited

Simple to use, portable health check device, built for Bharat,
enabling specialized tests, tests for infectious diseases, markers,
basic vitals, blood and urine tests

Unique Selling Point: Portable device that can check 35 parameters withinstant results

Present stage of Development
Prototype, MVP

Product Positioning: A device to conduct tests, get instant readings, print,
WhatsApp reports to patient or doctor for prescription.

Geographical Region Targeted:
Rural India

National/Societal relevance: Solve the issue of lack of access to diagnostics
in rural India.

Cost:
Rs. 2.50 Lakhs

Import Substitution: Yes

Units sold:Being launched at this event

Export Potential: Yes.
Product Picture

IP Status:
Patent filed

y
y
y
y
y

Contact detailsv

SANDEEP BHATIA

Major Achievements(including awards):
Atal New India Challenge 2.0 Award
from Niti Aayog
Amrit Jan Care Award from BIRAC,
Department of Biotechnology (DBT),
Government of India
Startup India Seed Fund Award
Nidhi Prayas Grant, DST, Govt. of
India
Best Exhibition Award at Impact
2.0 Conclave organized by Pune
University and Head Start

Email
Websitewww.helohealth.in

55

56

Startup Name

Product/Technology

Himalayan Hemp Industries Pvt. Ltd

Himalayan Hemp Sanitary Pad

Unique Selling Point: Rash-resistant, compostable, highly absorbent, World’s
1st hemp sanitary pad

Present stage of Development
MVP
Geographical Region Targeted:

Product Positioning: B2B2C
National/Societal relevance: It is world’s 1st hemp sanitary pads which will
be handstitched by local artisans and raw material will come from farmers.
Import Substitution: Yes. It can replace other healthy sanitary pads
Export Potential: Hemp sanitary pads have huge demand across the world.
Product Picture

Export regions, rural parts of India andtier 1 cities of India

Cost:
349rs / 3 pads in a pack

IP Status:
Patent applied and published (Patentapplication no: 202121000719 A)

Major Achievements(including awards)
Quantum: INR 5,00,000
Funder: NIAM, Jaipur (RABI RKVY)
Quantum: INR 10,000
Funder: Department of Science andTechnology (India International Science
Festival - Nav Bharat Nirmaan)
Quantum: INR 3,65,000
Funder: Amrita TBI, Kollam (Nidhi EIR)
Quantum: INR 50,000
Funder: FICCI FLO
Quantum: INR 70,000
Funder: ICA Asia Pacific (with Amul
and SEWA)
Quantum: INR 49,20,000
Funder: BIRAC
Quantum: INR 30,00,000
Funder: Punjab National Bank

Contact details

Mobile No: : +91 8219655168

Emailcommunity@himalayanhemp.in

Websitewww.himalayanhemp.in

57

Startup Name

Product/Technology

HospitoHospito is making affordable SaaS for Diagnostic Labs tomake the day-to-day lab management process more efficient.
On top of this, this product will enable diagnostic labs to bediscoverable online

Unique Selling Point: Currently, no such diagnostic aggregator exists thatbrings patients and diagnostics labs on a single online platform
National/Societal relevance: They aim to create a platform that is trusted bypatients and provide blood test services at an affordable price with a premium
experience on top of that we aim for the betterment of standalone diagnostic
labs by providing them technology (which they really need) and business.
They also have a blood bank portal running, which is built over E-rakthkosh
open APIs and helps you to find a blood bank near you in cases of emergency.
Import Substitution: In India, they are providing the best technology at thelowest price. Therefore diagnostic labs using foreign software can partnerwith us.
Export Potential: The price for the software is very less compared to theInternation market, so it creates a scope to expand globally after making thefinal product after testing.
Product Picture

Contact details

58

Mobile No: : +91 9568561582

Present stage of Development
They have done our market research
and will have our MVP by
Mid February, 2023.
Geographical Region Targeted:
Initially Roorkee for testing andvalidation, we will then expand to tier-1
cities (Delhi, Noida, Gurugram)Cost:
Rs. 500 per month (subscription-basedmodel) for diagnostic labs

Major Achievements(including awards):
Received a grant of Rs. 7 lakhs fromTIDES, IIT Roorkee

Emailhospito.in@gmail.com

Websitewww.hospito.inStartup Name

Product/Technology

IAPS Agritech Pvt Ltd

AppleDOC – An Artificial intelligence-based decision support
system for precision apple farming.

Unique Selling Point: Customized spray schedule for each orchard, locationand farm specific advisories, orchard specific weather updates, digital soil
health cards and actionable plans, disease and pest prediction and forecast.

Present stage of Development
Beta-testing-platform is currently
being tested by 1000 growers.

Product Positioning: AppleDoc is the “First Apple Specific AI driven Decision
Support System for farmers”, and it would be compliant to Agri 4.0 revolution,and in the most easy to understand format.
It is specific to cohort associated with apple industry like apple growers, policy
planners, state agriculture universities, experts, pesticide dealers, nutrition
dealers, CA stores and buyers.
National/Societal relevance:

Geographical Region Targeted:
All apple producing states/regions inIndia (Jammu and Kashmir, Himachal
Pradesh, Uttarakhand)
Cost:
Platform is under testing phase, so fee isbeing charged.
Units sold:Currently are testing our platform with
1000 growers.

yyMajor Achievements(including awards):
Best startup award by SKUASTKashmir.
Excellent contribution in scienceand technology award from SKUAST
Jammu and SKUAST Kashmir.

Import Substitution: There are many competitors in the market nationallyand globally like Plantix, FASAL, CropIn etc. All of these are generic type DSS.
The adoption of any of these platforms is almost zero with the apple farmers,
because none of them suits to their specific requirements. AppleDOC being
developed organically, would overcome all the deficiencies, and the adoption
rate by farmers would be higher than 70% as per our preliminary survey.
Export Potential: We are launching our platform (AppleDOC) in Italy forcustomized fertigation and weather updates plans.
Product Picture

HomepageContact details

Nursery Page

Weather page

Dr Basharat Ahmad Bhat
Mobile No: : 9541556608

Connect with expert page
EmailWebsitehttp://getappledoc.com/
59

60

61

62

63

Startup Name

Product/Technology

IOTA DIAGNOSTIC PVT. LTD

Bio-Specimen Micro-sampler Device

Present stage of Development
Clinical Evaluation (TRL: 7)

Unique Selling Point: No unsafe blood reaches the patient ; Increaseavailability and reduction in wastage ; Traceability & accountability ; Quality
Assurance & Hemovigilance

Geographical Region Targeted:
India

Product Positioning: NA
National/Societal relevance: Bringing affordable and accessible diagnostic
reach for 70% rural people of India

Cost:
110 INR/kit

Import Substitution: Mitra Microsampler, Whatman 903 Card, and Dried
Blood Spotting Card.

Units sold:
30

Export Potential: In South Asia, Middle East Africa, United States of America
and Europe

IP Status:
Patented

Product Picture
y

y

y

y

Contact detail

64

Mobile No: : +91 98987-21622

Major Achievements(including awards):
Mr Vaibhav Shitole was awarded
the
BIRAC
SITARE-GandhianYoung Technological Innovation
Award-2020 and a 1,500,000 INR
Grant for the development of ablood micro-sampling device.
IDPL has been recognized as aStartUp under Department for
Promotion Industry Internal Trade,Govt. of India.
Recognised Emerging Start-up in
Biotechnology by Entrepreneurship
Development Institute of India,
felicitated by hon. Shri Ashiwini
Vaishanv, Union Minister of Railway.
Selected in ‘top 150 Startup’ by
Lemon School of Entrepreneurship

Email
Websitehttp://iotadiagnostic.com/

Startup Name

Product/Technology

ipanelKlean Solar Pvt Ltd.

ipanelKlean – A disruptive patented technology in waterlesssolar panels self cleaning system

Unique Selling Point: Increases solar power generation upto 100%, Reduces
payback period upto 40%, Gives IRR from 28% to 81%, that too without
additional rooftop space or land area.
It does not have any moving parts on solar panels, it is brushless and automatic,
only technology that is successful on both rooftop and utility solar segments,
has over 25 years system life and very low maintenance cost.

Present stage of Development
TRL – 6 to 8
Geographical Region Targeted:
India, Middle East, Africa, US, South East
Asia, Australia, Japan and Korea

In this we first make the solar panels slippery using nano-coatings suchthat the dust wont stick to them and then loose dust is blown clean using
compressed air. The process is repeated multiple times a day.

Rs 22000 to Rs 27000 per kW

Product Positioning: Solar Power Plant owners and investors in rooftop andutility segments including commercial, industrial, hospital, institutional andresidential.

83kW (pilot orders in various stages ofprogress)

National/Societal relevance: ISolar plants loose power generation upto 70%
in rooftop segment and upto 33% in utility segment due to dust deposition,
there is scarcity of water in cleaning them (with water table dropping upto
2m/year, by 2030-40% of India wont've access to fresh water, a reportof NitiAyog), there's risk to life of solar panel cleaning workers due to highvoltage DC electrocution and falling while working. As per NCRB report 13k+
accidental deaths are due to electrocution (with 59% at work place lack ofsafety practices) and 10k+ deaths due to falling from heights. ipanelKlean
solves them all.
ipanelKlean is disruptive patented technology in waterless solar panels
self cleaning system that upto doubles the power generation. It has large
economic, environmental and social impact globally by potential annual extra
revenue of 8 Bilion USD, saving 100 billion litres of water, saving 60 million
tons of carbon emissions and saving lives of numerous solar panel cleaning
workers from high voltage DC electrocution or falling while working.
Import Substitution: Presently, high end robotic solar plants are very
expensive to import. Our technology will completely replace them.
Export Potential: YThe export potential is for 11 to 15 Billion USD world wide,
since there is 629 GW solar plants installed in the world, which are growing@30% CAGR, considering 25% as serviceable addressable market (SAM) it
gives us an export potential of 11 to 15 Billion USD worldwide.

Cost:
Units sold:

IP Status:
Our India patent number is 317731. PCT
has been filedyMajor Achievements(including awards):
Selected by Niti Ayog Among
Disruptive technology during India
PV Edge 2020, Selected by US
Embassay initiative among top 3
startups combatting climate change
in India, Selected by CapitalandSustainability X Challenge ofSingapore among top 10 startups
globally and doing a pilot withthem, selected by Sustainability
Association of Singapore, among
top 12 startups globally 2 times,
selected by McKinsey among 200
global startups, Selected by SJVN
for a pilot at their Charankha solarpark etc

Product Picture

Contact details

ipanelKlean Solar Pvt Ltd
Mobile No: : +91 9910228861

Websitewww.ipanelklean.com

65

66

Startup Name

Product/Technology

Janitri Innovations

Keyar-Daksh

An affordable & easy to use labor monitoring device KEYAR for early detectionof fetal distress by monitoring Fetal-maternal heart rate & uterine contractionin healthcare settings has the potential to prevent neonatal mortality &morbidity. In low resources healthcare settings where a cesarean facility is
not available, the early detection of fetal distress will help low-skilled healthworkers in the early decisions for referral to higher health facilities. KEYAR
communicates with our mobile application DAKSH which is an intrapartum
monitoring mobile application for an automated partograph generation.
DAKSH allows the staff nurse to register and enter vital signs of a pregnant
woman. It reminds the staff nurse to monitor the labor vitals, as per the
standard WHO intrapartum protocol. It also generates alerts in case ofcomplications, based on an in-built algorithm.

Present stage of Development
Scaling
Geographical Region Targeted:Low-middle income countries like India,
Africa, Afghanistan, etc

Cost:
30,000 INR -1,50,000 INR, productmodularity.

Units sold:
200+

Unique Selling Point: Automated Partograph, Remote monitoring, AutoInterpreted Fetal Reports, Digital reports, Mother’s Mobility

IP Status:

Product Positioning: B2B, B2C

12 patents filed, 4 granted

National/Societal relevance: In India almost 70% of the population live inrural areas and availability of blOverwhelming focus on sick care rather thanpreventive healthcare has been the cause of burgeoning health expenditureand increasing disease burden across the world for a few decades. Alongwith that, health disparity in urban and rural areas has also been known fora while. So there is a necessity to have a comprehensive, coordinated, andcontrolled action plan to reform the public primary health care in India. This
creates a scope to the new evolving technologies, having much affordable andaccessible quality care to serve the last mile. This is possible by collaboratingwith both Private and Public healthcare sectors in India, which will yield morelucrative results in the future. So, we at Janitri are working with a vision to see
a world where no woman or newborn dies during pregnancy, delivery or after
delivery.

y
y
y
y
y
y

Import Substitution: CTGyExport Potential: WorldwideyProduct Picture

y
y
y
y
y
y
y
y

Contact details

Mobile No: : +91 8387014808

WebsiteMajor Achievements(including awards):

KEYAR at ASME iShow 2017
InsightSuccess | The 10 Most Admired
Medical Device Companies in 2017
Deccan Herald | Startup showcases
device to ensure safe delivery
YourStory | Janitri’s portable smart
device monitors mother and baby tokeep them safe through childbirth
Medicall | Silver Winner
Janitri at Falling Walls Venture 2019
| Breaking the Wall of Maternal andNewborn Mortality
Janitri at NDTV live campaign "Swasth
Banega India"
Economic Times | Bill & Melinda Gates
Foundation-backed Janitri is preventing
newborn deaths in rural India
4th Commonwealth digital health Meritaward in the Maternal & Neonatal
health category Janitri at BBC Show | Gujarati
Janitri at BBC show | Tamil
Winner at 12th IoT/WT Innovation World
Cut in Healthcare Category 2021
Janitri is one of the notable mentions in
PATH PHC tech challenge in MedTech
Category.
5th ICT Startup Awards by ASSOCHAM
Janitri has been announced as the leadwinner for # CARE startup challenge inthe category of Mother and Child Care.
Public Health Innovation Conclave Hyderabad TOP
INNOVATOR
at
Innovations Arena 2021.

www.janitri.in
67

Startup Name
JC OrthoHeal Pvt Ltd.

Product/Technology
FlexiOH: The NextGeneartion Orthopedic immobilization
technology
Present stage of Development
Commercialization

Unique Selling Point: FlexiOH is a Breathable, washable & lightweightimmobilization device for fractured bone and skeletal injuries. It is easy toapply on affected body parts, customizable according to body shapes & alsoeasy to remove after its use.

Geographical Region Targeted:
Global

Product Positioning: FlexiOH is addressing strong clinical need from patientperspective, Patient undergoing cast treatment, suffers from poor skinhygiene, lot of hassles related day to day activities and lot of discomfort.
FlexiOH is comfortable, convenient and efficient clinical solution for orthopedic
injuries which reduces skin related complications.
National/Societal relevance: FlexiOH™ is a technology which is completelydeveloped in India by Indian innovators considering not just Indian healthcare
situation but for global healthcare goals. Apart from that manufacturing
technology going to be used for production FlexiOH™ is also compatible for
Indian manufacturing ecosystem. India is a second most populated country in
the world and still developing infrastructures hence requirement of healthcaretechnology is more compare to any other country in the world. India isrepresenting developed as well as developing situation because of large gap
in resources availability to general population. There is also huge number ofpeople suffering from bone fractures mainly because of road accidents andtrauma. Inventor of the FlexiOH™, who is also a founder- MD of the company,
is strongly considering manufacturing setup in India even though product isgoing to be marketed in India, USA, Canada and Europe. We have projected
5% market coverage in 2027. The Make in India Campaign will help us to makeour projections into reality. As per our projections, we are going to generate atleast 1000 direct and indirect employment by 2027
Import Substitution: Most of synthetic cast are being imported, we canconsider particle import substitution with FlexiOH
Export Potential: Already exporting in 45+ countries with Major focus in USA
and Europe.
Product Picture

Contact details

68

Dr. Pankaj Kumar Chhatrala
Mobile No: : +91 800915015

Cost:
Rs 2,500/- to Rs 14,000/-

Units sold:
12000 units

IP Status:
We have filed an Indian patent withpriority number: (3237/DEL/2014) and
PCT application (PCT/IB 2015/058579).
patents granted in USA.

Major Achievements(including awards):
1)

BIRAC-SRISTI Gandhian Young
Technological Award 2015
2) BIRAC- SRISTI Gandhian Young
Technological Grant 2015
3) Biotechnology Ignition Grant 2015
– BITAC- DBT- GoI
4) Gold Medal DST- Lockheed Martin
India Innovation Growth Program2016
5) IC2 commercialization Support fromIC2 Institute, University of Texas –USA on being in top 8 Technology
under DST- Lockheed Martin India
Innovation Growth Program- 2016
6) IUSSTF Silicon Valley Delegate visit
on being in top 10 Technology underDST7) Lockheed Martin India Innovation
Growth Program- 20168) Top 10 promising start-up under CII
industrial innovation award 2016.
9) BIRAC- Biotechnology Industry
Partnership Programme (BIPP)
Scheme- 201810) BIRAC-National Biopharma Mission(NBM)-2020
11) BIRAC-Grant Challenges India (GCI)2021

Emailwww pc@orthoheal.com.bagmo.in

Websitehttps://orthoheal.com/

Startup Name

Product/Technology

Jouls Ecotech Pvt. Ltd

Smart Electric Vehicle Charger for Residential Application

Unique Selling Point: 30% efficient, 10x faster technical support
Product Positioning: Premium Smart Electric Vehicle Charger.
National/Societal relevance: The proposed charger allows users to makethem more sustainable, allows to have better charging experience. User cancharge with 100% solar power which allows adoption of rooftop solar panels.
Their vision is to create innovation & bring inspiration for people to transit
towards sustainable lifestyle
Import Substitution: 10 %Present stage of Development
Product Development,
MVP Development
Geographical Region Targeted:
India
Cost:
50,000 (tentative)
IP Status:
In Progress

Export Potential: Can be exported
Product Picture

Major Achievements(including awards):
Won 1st prize BIT-NISHAN (College
Competition), Won 2nd prize in Energy
Hackathon organized by RRECL.

Contact detail

Mobile No: : +91 6377650430

Emailamangoyal6377@gmail.com

Websitewww.jouls.energy

69

Startup Name

Product/Technology

Kidaura Innovations Pvt. Ltd.

1. ScreenPlay - Game & AI based Screening tool for autism.
2. Kidaura - A therapy management platform for therapy centers

Unique Selling Point:
1.

ScreenPlay - Games based screening tool, language independent, AIbased.

2.

Kidaura - Progress tracking, Data based insights, Home-reinforcementof therapies, Therapy related documentation, In built- Assessment, IEP.

Product Positioning: Kidaura offers innovative solutions for early identificationand management of autism in children through ScreenPlay, a game-based
digital screening tool and Kidaura Care, a therapy management platform.
ScreenPlay is fun, non-intimidating, convenient and accessible, Kidaura
Care provides an efficient way to document, track progress and manage
appointments for therapy centers.
National/Societal relevance: Kidaura's products, ScreenPlay and Kidaura
Care, are highly relevant to society as they support children with autism andtherapy centers. ScreenPlay is a game-based digital screening tool, Kidaura
Care is a therapy management platform, both help in early identification,better therapy management, and better outcomes for children with autism
and their families.
Export Potential: ScreenPlay, a game-based digital screening tool for autism,
and Kidaura Care, a therapy management platform, can be easily exported
globally with minimal barriers to entry. Both products are in high demandfor early identification and management of autism worldwide, especially incountries facing difficulties in therapy centers management.
Product Picture

Present stage of Development
1. ScreenPlay - Under clinical trials.
2. Kidaura - Launched in May 2022.
Geographical Region Targeted:
MENA and South East Asia
Cost:
1. ScreenPlay - INR 500 per child
2. Kidaura - INR 599 per child per month

Units sold:1. ScreenPlay - NA
2. Kidaura - More than 15+ therapy
centers across MENA and south east
Asia

IP Status:
1. Patent published - ScreenPlay(application number : 202021026125)
2. Trademark granted : Kidaura

Major Achievements(including awards):
1.
2.

3.
4.

Winner of the BIRAC-Social Alpha
Quest for Assistive Technologies.
Winner of TIDE 2.0 grand challenge- a startup funding program of
MEITY.
Winner of BIRAC- BIG 17.
Part of Anjal Z Techstars Founder
Catalyst powered by the Abu Dhabi
Early Childhood Authority

1. ScreenPlay

2. Kidaura Care
Contact details

70

Mobile No: : +91 7791980877,
7009105996

Websitewww.kidaura.inStartup Name

Product/Technology

Knowledgepie Pvt. Ltd.

Knowledge is developing a nanoparticle based contrast agent formagnetic resonance imaging (MRI) which can perform dual functionalities of diagnostics and therapeutics. They are safe in normal
cell lines and will be tested in renal impaired rodents. Once tested,
it will overcome the nephrogenic systemic failure (NSF) issues associated with conventional Gd-based contrast agents present in
the market. These nanoparticles were synthesized by an aqueous,green and cost-effective technique and the aqueous solution of it
is highly stable in nature.

Unique Selling Point: The raw materials for Gd-based contrast agent
are mostly imported to India. Hence contrast agent will be the “First to
market” “Make in India” product in this regard. Secondly, the same contrast
agent possesses both diagnostic and therapeutic property. Thrid and mostimportantly, this contrast agent overcomes the NSF issue associated withcurrent CAs.

Present stage of Development
TRL 4
Geographical Region Targeted:
India

Product Positioning: India’s first self developed contrast agent for MRI andworld’s first MRI contrast agent possessing both diagnostic and therapeutic
effects.

Cost:
Rs. 1250 per bottle of 10 mL

National/Societal relevance: Over the last decade, magnetic resonanceimaging (MRI) has become established as a useful referral diagnostic method
in medicine. The use of MRI has grown due to its unparalleled capability to
produce high-contrast, anatomically detailed tomographic images of soft
tissue structures. Unlike radiography and computed tomography (CT), which
use attenuation of an x-ray beam to create an image, techniques that use
magnetic resonance (MR) do not reflect changes in tissue density. Instead,
MR uses the electromagnetic signal emitted from protons in different tissues.

Units sold:NA

However, contrast agents are as important as the technique itself. The
conventionally used ones are Gd3+ and Mn2+ based complexes which
work as T1 weighted contrast agents. Where, Mn2+ is considered as thetrace element in mammals body composition and Gd3+ is not a part of it
in normal condition. Hence, toxicity issues are always accompanying the
success ends of these contrast agents. We are proposing a contrast agent
based on FePt nanoparticle composite capped with biocompatible ascorbic
acid. The proposed contrast agent will be able to reduce the toxicity concern
significantly whereas its applicability as a therapeutic agent also will enableobtaining multifunctionality within a single entity. Most importantly, thesynthesis technique used to develop the proposed contrast agent is a very
facile, one pot process which can be executed with minimal facilities.

IP Status:
Indian patent granted to synthesis
technique (Indian Patent Reference no351940)Major Achievements(including awards):
Recipient of BIG (18th Call) grant of Rs
50 lacs
1st position (cash award Rs.
5000) in “Innovative idea competition”
in a workshop conducted by Kaziranga
University, Assam, DPIIT Chair, Tezpur
University and NRDC, New Delhi.

The high yield, facile synthesis technique used to develop the proposed contrast
agent and the higher relaxivity data of the developed FePt nanoparticles willcertainly result into a commercial product which can dominate the contrast
agent market in near future
Import Substitution: In India, the raw material for developing GBCAs aremostly imported. Hence, our product will be an import substitute in this regard.
Export Potential: The product is the first one with simultaneous diagnostic
and therapeutics. Hence, it has huge export potential.

Contact details

Mobile No: : +91 8876059434

Websitehttps://knowledgepie.in/71

Product/Technology

Startup Name
Krimmi Biotech LLP

A Novel Eco-friendly process to induce the silkworm to produce
naturally colored silk fibre of desired choice with increased yield

Unique Selling Point: The technology to produce a naturally coloured cocoons(non-woven silk fabric.) -also proposed through a novel technique of forced
induction of planar silk. -The proposed planar silk can be value enriched forbiomedical applications, undergarments, sportswear’s etc. through thistechnique. - Reduced dependency on water and controls environmental
pollution and Reduced dependency on Synthetic/Carcinogenic dyes
Product Positioning: Both B2B (with reeling industries )and B2C (Sericulture
farmers)
National/Societal relevance:y

The proposed product helps to increase the yield with desired choice of
color

y

This technology also eliminates the usage of synthetic dyes which leads
to environmental pollution.

y

No major producers of planar natural colored silk in IndiayGovernment supports for avoiding the usage of carcinogenic dyes

Import Substitution: The technology is already in discussion with Sericulture
Association of India, Karnataka State Sericulture Department, FPO’s etc.,
e-commerce companies like Nilima Silk for future commercialization of our
products.

Present stage of Development
The products developed under BIG
Scheme are validated and conducted
field trials. The products are anticipatedto be commercialized in next 6 months.
Geographical Region Targeted:
The target area is entire Southern India
and have done preliminary survey ofthe proposed technology and sufficientinterest among the realer and farmers
who can get an additional revenue.
Cost:
Average Price: (INR 220/- per 50 ml tube
(prices varies with colour))Units sold:NA
IP Status:
Two patents filed on “Inherently Colored
Silk with Increased Yield” and “Novel
Device to Produce Planar Silk for
Biomedical Application”
Major Achievements(including awards):
Received ‘Successful Entrepreneur
Alumni Award’ from Sir.MVIT Bangalore
and Received ‘BIRAC Innovator Award’
from Hon’ble Union Minister Piyush
Goyal during Global Bio India at New
DelhiContact detail

72

Deepak Bajantri
Mobile No: : +91 9916916989

Emailkrimmibiotech@gmail.com

Websitewww.krimmibiotech.com

Startup Name

Product/Technology

Krisham Healthcare

Herbal Mosquito Repellent/Vector Control

Present stage of Development
Product ready to be launched

Unique Selling Point: 100% natural, pure and safe ingredients with highly
effective mosquito repellent activity and skin care benefits like moisturization,
anti-inflammatory, hydrating and nourishment
Product Positioning: Our 100% natural mosquito repellent product range
offers complete protection against mosquito bites to customers of all ages
and skin types (oily to normal, normal to dry, dry and sensitive). They also offera body roll-on for frequent travellers and vaporizers for all night protection
catering to all domestic users and guests in hotels/resorts. They offer wide
range of toxin-free, safe products with skincare benefits and no adverse
effects for consumers that can be used indoor as well as outdoor.
National/Societal relevance: The recent years have seen a dramatic increasein mosquito vector transmitted viral diseases like Dengue, Chikungunya,malaria, Zika, yellow fever, Lymphatic filariasis, Rift valley virus fever andJapanese encephalitis etc. A key strategy to control the spread of these deadly
diseases is to effectively control the vectors. In this context, development ofmosquito repellent products could be invaluable for protecting individuals
from mosquito bites as well as reduce the mosquito burden by curbing theirbreeding. Most of the commercial mosquito repellents use the chemicalcompound N,N-diethyl-m-methylbenzamide (DEET) available since 1946.
But its use has been limited by side-effects ranging from skin rashes toneurological disorders. Other options like the piperidine analogue picardin andpyrethroids also pose health hazards to humans on prolonged exposure. A
recent study had shown that the commercial mosquito repellent mats andfilms emitted over 230 volatile organic compounds, prolonged exposure towhich can lead to health complications. Further, many mosquito species havegained resistance to extensively used chemical repellents. Our herbal vector
control products from Krisham® serve as safe and highly efficient mosquito
repellents and also help in skin care by nourishing, hydrating and moisturizing
the skin and imparting anti-inflammatory, anti-bacterial and anti-ageing
properties. Further, they also indirectly contribute to promoting plantation of
the plants from which the raw materials (phytochemicals) are sourced thereby
keeping the environment green. .
Export Potential: Has export potential to US, Australia, Asian, South Americanand African countries that also have mosquito control issues.

Geographical Region Targeted:
Tropical and temperate regions withmosquito infestation
y
y
y
y
y

Cost:

Mosquito repellent cream: Rs 40(10 g), Rs 185 (50 g), Rs 360 (100 g)
Mosquito repellent lotion: Rs 75 (30mL), Rs 130 (50 mL), Rs 245 (100mL)
Mosquito repellent body butter:
Rs 120 (30 g)
Mosquito
repellentvaporizer:
Rs 145 (40 mL), Rs 190 (one 40 mL
bottle with vaporizing unit)
Mosquito repellent body roll-on:
Rs 45 (10 mL)

Units sold:
Products to be launched in March 2023
for commercial sale
IP Status:
Patent application being drafted; Field
trials underway
Major Achievements(including awards):
DST-NIDHI PRAYAS award,
Dermatologically tested; Good feedback
from consumers on aroma, texture
and repellent activity; First mosquito
repellent body butter

Product Picture

Contact details

Uma Maheswari Krishnan
Mobile No: : +91 9894366263

Emailkrishahealthcare2022@gmail.com

WebsiteUnder construction73

Startup Name

Product/Technology

Kwaklei and Khonggunmelei Orchids Pvt. Ltd

Hybrid orchids

Unique Selling Point: Hybrid orchids of Indian origin
Product Positioning: The major target customers are the Indian orchid
cultivators and the tissue culture laboratories that do commercial
micropropagation. Most of these firms depend on other heavyweight orchid
producing countries and thus pay heavy import duties. If the products canreplace and reduce the import load to certain extent initially, it will be acommendable effort. Our orchids will be more suitable in the different agroclimatic conditions in India for cultivation, than those imported ones. Moreover
our orchids are of Indian origin.

Present stage of Development
Hybrid orchids which were developed
under the BIG and SBIRI schemes areat pre-commercialization stage. Someof the orchids have flowered and forcommercial production clonal propagation via micropropagation is being
conducted.
Geographical Region Targeted:
GlobalNational/Societal relevance: India, despite having rich orchid resources, has
not been able to translate the resource into economy. There is the potential fora flourishing orchid industry in India and this would require dedicated orchid
breeders to feed the requirement of new varieties and planting material fromtime to time. India can also be an exporter of good quality orchids.

Cost:
Rs. 500 per flask (TC plants); Rs. 50/to Rs.500/- per plant (greenhousecultivated plants depending upon theirage or size)

Import Substitution: Many orchid cultivators, hobbyists as well as tissue
culture commercials labs will be benefited by our effort and product. The
import loads by this business sector will be minimized to certain extent. New
and novel orchid varieties developed in India can be exploited commercially.

Units sold:>2000/IP Status:

Export Potential: It is definitely there since orchid industry is a global industry.

Two Patents Applied

Product PictureyyyContact details

74

Dr Rajkumar Kishor
Mobile No: : +91 9856664628

Major Achievements(including awards):
Icons of Asia ‘Entrepreneur of theYear (Innovation in Technology)’2022. Conferred by Global Empire
Events and Biz Nation TV, New Delhi
Dr. S. P. Vij Memorial Award, 2022.
Conferred by the Orchid Society ofIndia (TOSI)
Dr. Ibeyaima Innovation Award –2018 for Hybrid Orchids, Manipur
Science and Technology Council(MASTEC), Sponsored by Manipuri
Association of Canada, Ontario.

Emailrajkumarkishor@yahoo.com

Websitewww.kwakleikhonggunmeleiorchids.com

Product/Technology

Startup NameLab Iconics Technologies LLPLAB ICONICS LIMS (LABORATORY INFORMATION MANAGEMENT SYSTEM) and ELN (ELECTRONIC LAB NOTEBOOK)

Unique Selling Point: Lab Iconics LIMS – ELN offers many unique features likey Sample Management and Experiment Management for QC and R&D
Workflowy Custom Fieldy Ease of Master Creation by Single time Test Registrationy Test Variables for custom calculationy Configurable Dashboard
y Default Remarksy Configurable E-Signature Workflow
y Simplified and Ease of Operationy Modules for Inventory, Analyst Qualification, LDMS, Label Management,
Stability Management, Instrument Management, Retain Sample, etc.,
y Meets regulatory compliance requirements like 21 CFR Part 11, EU Annex
11, GAMP5, ALCOA+
Product Positioning: B2B

Present stage of Development
Pre-Commercialization - ProductLaunched to Market, Beta Testing andValidation in progress
Geographical Region Targeted:
International
Cost:
INR: 10 - 35 Lakhs

Units sold:Yet to be sold, Integrated LIMS – ELN isscheduled to launch during Mar 2023

IP Status:

National/Societal relevance:
1. Augment or improve upon human intelligence
2. Increase the speed and quality of decision making
3. Improve transparency, traceability and auditability

Trade Mark Registration approved for
Lab Iconics LIMS, ELN and ADBS

Compliance burden removed and product quality is improved by automating
critical quality processes like document, training, quality event and productrelease management in a single end-to-end solution. When quality data is
digitized, collected and integrated, it becomes a business-wide commoditythat has the power to influence change and improvement across the entire
product life cycle. LIMS helps the laboratory to maintain the custody of sample
chain and data management, ensure compliance, right product to consumers
on time.
Import Substitution: Yes. Currently Indian Pharma and Biotechnology
industry is dependent on laboratory applications from US, UK and European
Suppliers. With the launch of Lab Iconics LIMS, we can provide solution which
is made in India with all quality and regulatory standards at affordable costwith quality and compliance.

Major Achievements(including awards):
1.

Best Innovative Technology Award
from Indian Society of Analytical
Scientists (ISAS) at Analytica Anacon
India LabExpo, Mumbai - April 2022

2.

MSMECCII Excellence Award 2020

3.

India 500 Startup Award for year
2019

Export Potential: Yes.Studies found that blood supply chain complexities
in developing countries like : expiry time, temperature and transportation
requirements, supply and demand gap etc. Many low income countries stillpractice unbanked directed blood transfusion which can be avoided by having
effective blood supply chain monitoring solutions.
Product Picture

Contact details

Raveendranath Govindaraj
Mobile No: : +91 8008001805

Emailraveendranath@labiconics.com

Websitewww.labiconics.com
75

76

77

Startup Name

Product/Technology

Machphy Solutions

Cold Chain for Biotech and Medical sector

Present stage of Development
Commercialised

Unique Selling Point:yPower backup upto 48 hrs without battery or electricityy

IoT monitoring and preventive maintenance with lowered TATy

OPEX modelsyRenewable power interface

Geographical Region Targeted:
India & Southasian countries, Africa

Cost:
3500 to 4,50,000

Product Positioning: For rural and semi-urban India where cold chain gets
expensive due to lack of proper infrastructure. Helps save logistics operators
lower upto 50% of operating expenses.

Units sold:3000

National/Societal relevance: Highly relevant to Indian Societal scenario
majorly benefiting the Healthcare and Biotech Industry in strengthening the
supply chain in Tier-2 cities of India. Also has a potential to impact more than
100 Million lives in India by improving the Blood Bank chains in rural India
Export Potential: upto $5M to South-Asian countries and African Nations.

IP Status:
5 Patents filed in IndiayyyContact details

78

Mobile No: : +91 7978457552

Major Achievements(including awards):
Awarded Pilot project with World
Bank-IFC in Bangladesh , 2022
Awarded by Cabinet Minister Shri
Purshottam Rupala for impact inAnimal Husbandry, 2022
Awarded BIG-BIRAC grant for PoC,
2019

Email

info@machphy.com

Websitewww.machphy.com

Product/Technology

Startup Name
Manastik Technologies Pvt. Ltd.

Teleneurology & Teleneurorehabilitation product catered
towards Neurology healthcare ecosystem

Unique Selling Point: One-stop solution in the entire dementia ecosystem.
Product Positioning: As of now, product is published in Google Play in internal
testing track.
National/Societal relevance: Firstly, through the use of CMR feature (Cloudstorage of Medical Records), users including doctors can store medical records
and access from anywhere on the go.
(Doctors for all purposes here mean Neurologists, Neuropsychologists,
Neuro Therapists and SLPs/SLTs in the domain of Neurology/Neurosurgery/
Cognitive Neuroscience)

Present stage of Development
TRL-6, in the prototype stage, moving
it to production environment.
Geographical Region Targeted:
Maharashtra (Pune, Mumbai), Delhi
Cost:
200 Rs/month & comission based modelon teleconsultation
Units sold:NA

In today’s world, old age people are mostly rejected unfortunately. Not manycare about them, especially new generation. Further, in dementia, people
hardly bother about what they are going through. We are trying to bring about
a positive change in their lives including the entire family.
Export Potential: Given the increasing rate in mental health disordercommunity off late, there is a certain need of this in these countries/
continents. Moreover, in some places patient awareness needs to be brought
about first in order to ship this product.
All in all, there is a huge export potential, which is in plan when the productcrosses Phase 3 release in Indian market.

IP Status:
We are working to get the IP finalized
and file a patent.

yyyProduct PictureyyContact details

Mobile No: : +91 7588285664
9172665769

Major Achievements(including awards):
BIRAC BIG Grant Awardee (2022)
IFNR Young Investigator of the YearAward (2022)
ASEAN-India
StartupFestival(2022), selected amongst 30
startups to represent India at Bogor,
Indonesia
Presented Project at IFNRCON 21(2021)
Presente Project at AOCNR (2021)

Emailsoubhik.das@manastik.com

Websitewww.manastik.com

79

80

81

Startup Name

Product/Technology

Mediklik Webhealth Pvt Ltd

VENSI Next Generation Advance Ventilator

Unique Selling Point:
Universal Application – Adult Paediatric and Neonatal Ventilation
Zero Running cost - No flow sensor needed (Integrated reusable flow sensor),
No bacteria filter needed (Integrated UV filter)
Zero Cross Contamination - Smart Sterilization monitoring
Lung protective Ventilation SmartVent - intelligent ventilation mode,
PVTools - Easier lung recruitment PulmoSmart - Real time Lung Graphics,
SmartWean - Faster and easier weaning
Brilliant User Interface- Customized to suit user needs, Gesture control
Guaranteed performance - 20000 hours guaranteed lifetime
Product Positioning: B2B – it is required in corporate hospitals, Private
hospitals and in Nursing homes B2G – product is required for Research
institutes, all medical colleges and in all government hospitals.
National/Societal relevance: Over 3.6 million people die each year from
respiratory illness in India alone. Over 46 percent of these patients die due tolack of Mechanical Ventilator. Per WHO standards, India itself currently needs
an additional 1 Million Ventilators.
Though they have few manufacturers who came up with some make shift
solutions during the time of COVID, but unfortunately none of such solutions
are built on international safety guidelines and hence are not useful for criticalpatients.
So still, 95% critical care ventilators used in India are imported and they are
not only unreasonably expensive but they have high running cost due tomonopoly on consumables.
With VENSI they wish to change this scenario, and not only they will bemaking our country self-sufficient, but would also export the product to othercountries.
And with just 1/3rd cost of imported ventilator, VENSI can make healthcare
more reachable for the people of our country
Import Substitution: As briefed above, still 95% of our requirements are
fulfilled by foreign companies for critical care ventilator, with VENSI we can
not only replace these foreign products but can also bring down the cost to
1/3rdExport Potential: The overall global market is of US$ 3.2 Billion for advanceventilators and they product is designed and built with keeping in mind theinternational safety standards and requirements, hence they aspire to start
the export of the product as soon as possible.

Present stage of Development
Ready to License
Geographical Region Targeted:
Global market
IP Status:
Patent Application Number:
202121037769, A347994-001,
347995-001, 347993-001
Design registrations: A347994-001,
347995-001, 347993-001
Trademarks - 3409951
Major Achievements(including awards):
NA

Product Picture

Contact details

82

Mobile No: : +91 8770898770,
7898902455

Websitehttp://mediklik.com

Startup Name
Medlarks Private Limited

Product/Technology
Design and development of a device to prevent the Catheter Associated Urinary Tract Infections CAUTI in the patients indwelled with a urinary catheter.

Unique Selling Point: It is just an add-on device, not going to change theexisting catheter system and procedure as the foley catheter market is wellestablished

Present stage of Development
TRL4 (High fidelity Prototype ready forthe clinical validation)

Product Positioning: They are planning to sale product to the hospitals (bothprivate and the government).

Geographical Region Targeted:
All over the worldwide

National/Societal relevance: In hospital settings, there are over 15 million
CAUTI incidences and USD 31 Billion economic burden globally per year with
2.7 million cases in India alone. Each year, 63 thousand deaths in India and
359000 deaths occur worldwide. More than 100 million catheters.

Around 10k-20k/- (INR)

This small, add-on, effective, affordable and easy to use device can bring
the biggest transformation into urinary catheter systems since its inventionof Foley catheter in the 1930s. It can manage the avoidance of CAUTI in an
efficient manner to save thousands of lives per year.
Import Substitution: Yes, we don’t have much solution in India so it’s hightime to have solution in India.
Export Potential: Very much, where the hospital is very keen to prevent these
infection as it is not a part of insurance cover.
Product Picture

Cost:
Units sold:Not yetIP Status:
Device to prevent catheter associatedurinary tract infection
Indian Patent Application No.IN201811045665
PCT Application No.- PCT/
IN2019/050878/ WO2020115762A1
USA Application No.- 17/299446/
US20220118131A1
Japan Application No.- 2021-531783/
JP2022514820A GRANTED

Major Achievements(including awards):
They have developed a fully functional
prototype need to be validate andscale-up.

Contact details

Nirmal Kumar

Websitewww.medlarks.com

83Startup Name

Product/Technology

MedPrime Technologies Pvt. Ltd.

Cilika Digital Microscopes

Present stage of Development
Revenue generating (In-Market)

Unique Selling Point: Tablet integrated microscopes that enable digital sample
viewing, capturing, projection, live streaming and measurement without
any loss of magnification, resolution or field of view. Ideal for education,
diagnostics, research and telepathology
Product Positioning: Cilika microscopes are a range of digital microscopes(mostly B2B) which can be used in diagnostics, research, education, agriculture
or veterinary research. In terms of magnification, resolution and clarity ofsamples, Cilika microscopes are at par with any other branded microscope
available in the market, such as Olympus, Nikon, Zeiss, Labomed, etc. Cilika
provides the additional advantages of having digital zoom, unlimited data
sharing options such as WhatsApp, Telegram, email, Google Drive, local sync
as well as live streaming of the sample through Zoom, Teams, Google Meet,etc. There are 3 versions available – Cilika Portable, Cilika Benchtop and Cilika
Transform.
National/Societal relevance: Digitalization and automation of microscopes
opens up the potential to automate routine tests done regularly and to
employ machine learning and artificial intelligence to assist pathologists
and technicians in time taking samples. This will address the shortage ofpathologists and reduce the turnaround time for diagnostic tests
Import Substitution: No
Export Potential: Export to neighboring countries such as Nepal, Bangladesh,
etc is being explored. We are open to export to other Asian and Africa nations,subject to the presence of a suitable importer with necessary distributor withsales and service strength in the respective countries.
Product Picture

Contact detail

84

Greeshma Unnikrishnan
Mobile No: : +91 7506122866

Geographical Region Targeted:
Pan India
Cost:
INR 1 lakh - 3.2 Lakhs

Units sold:600
IP Status:
1.

Patent Granted-304199: Portable
upright bright field microscope withsmart device compatibility

2.

PatentFiled-201821000042:
Universal Digitization head for
integration of smart device withmicroscope

3.

PatentFiled-202021048690:
Digitization module for microscopes
to enable sample viewing on asmart device

Major Achievements(including awards):
Recipient of ACT grant, IHF grant,
BIG Grant, and SASACT Grant. Special
mention in ZS Prize 2021, Winner ofMagnetic Maharashtra Startup Awards
2018

Email

greeshma@medprimetech.com

Websitewww.medprimetech.com

Startup Name

Product/Technology
BrainoscopeTM

MEEALANTAAS (M-TAAS) Pvt. Ltd.

Unique Selling Point: BrainoscopeTM is an objective, scientific methodof analyzing an individual’s innate and acquired traits, characteristics andpotential. It helps individuals choose the right career stream.

Present stage of Development
Revenue Stage

Product Positioning: The biggest challenge in any service industry is finding
suitable buyers/customers and to encourage customer to purchase theproduct. Potential customers would be: Parents, job seekers, and employers.

Geographical Region Targeted:
Delhi-NCR

National/Societal relevance: IBrainoscopeTM is a real revolutionary servicebased product that has positively transformed lives of those who have opted
for it. It aligns the individual’s inborn potential and traits to suitable career
streams. Individuals become high performance professionals with minimal
input that in the long run makes them happy and content. The mental andphysical health and well-being of the individual in turn affects the family andsociety then nation as whole- we get full utilization of talent in the country
alongwith fulfillment of UN SDG of achieving Health for all.
Import Substitution: Yes
Export Potential: Yes.Studies found that blood supply chain complexities
in developing countries like : expiry time, temperature and transportation
requirements, supply and demand gap etc. Many low income countries stillpractice unbanked directed blood transfusion which can be avoided by having
effective blood supply chain monitoring solutions.

Cost:
10,000/- per test including counselling
Units sold:> 500 clients tested
IP Status:
Patent Pending
Major Achievements(including awards):
1st Position-National event on Women
entrepreneur at start-up stage, 8thMarch 2022.

Product Picture

Contact details

Dr. Meena Mishra
Mobile No: : +91 9910545338

Websitewww.meealantaas.com

85Product/Technology

Startup Name

Twance Divine X 100 - Wireless Active Noise
Cancellation headphone

Natswear Pvt Ltd

Unique Selling Point: Configurable noise profile, Wireless Active Noise
Cancellation headphone, Designed and manufactured in India.

Present stage of Development
Moving towards Production

Product Positioning: Target Audience – Professionals (IT, Management).

Geographical Region Targeted:
Pan India

National/Societal relevance: Twance is designed & manufactured in India[headphone design, PCB design, PCB fabrication and assembly and molding
being done in India].

Cost:
INR 7999

Import Substitution: Yes
Export Potential: Exploring the export opportunities.

IP Status:
Patent filing for Headphone technology

Product Picture

Major Achievements(including awards):yyyContact detail

86

Email

swetanjali03@gmail.com

Websitehttps://www.natswear.com

PATH - selected as one of the 12
startups for improving primary
healthcare in LMIC.
Finalists in Qualcomm Design India
Challenge 2020
Nasscom t4g - Technology for good
- Finalists 2019

Startup Name

Product/Technology

Natural bioceramics Pvt Ltd

Novel Nanohydroxyapatite Bone Graft Material

Unique Selling Point: The product is Nano in size and contains trace elements(Mg, Si & Zn) required for bone regeneration. It is Cost-effective; superior
in quality hence has the highest export potential. The availability of Nanohydroxyapatite from a natural source is scarce in the market.

Present stage of Development
TRL 5/6
Geographical Region Targeted:

Product Positioning: Buyers (B2B): Dental paste, cement, PharmaceuticalIndustry, and other Industrial manufacturers.

Asian Countries – initial stages for 2
years, later European and American
Market after 5 years

Users (B2C): Medical practitioners including orthopedics, Neurosurgeons,
Dental practitioners including oral and Maxillofacial Surgeons, Endodontists,and pedodontics use it as Graft Substitute.

1500 /CC

National/Societal relevance: The use of graft material prevents the burdenof the second surgery, morbidity, time required, etc. for harvesting autografts;
and the cost associated with manpower can be utilized for better service.
India largely depends on imported graft materials, the product reduces foreigndepends and acts as import substitution; Hence this has national and Societal
relevance.

Cost:
IP Status:
Applied, Application no. 201941017474

Major Achievements(including awards):
N/A

The product is sourced from a natural material that is eggshell. Hence useof eggshells removes waste & safeguards the environment. The technology
focuses on-waste to wealth products and Empowers hatchery. The production
technology is Environment-friendly, go-green - clean energy efficient
Import Substitution: The Nano-hydroxyapatite bone graft material is importsubstitution for various bone graft materials imported for clinical use like
Octabone, NOVABONE, MORSEL, Creos, DFDBA, DEMBONE etc. It will also
be an import substitution for raw materials required for the production ofdesensitizing and remineralization formulations and additive manufacturing
products
Export Potential: The product is Nano in size and contains trace elements(Mg, Si & Zn) required for bone regeneration. It is Cost-effective; superior
in quality hence has the highest export potential. The availability of Nanohydroxyapatite from a natural source is scarce in the market
Product Picture

Contact detail

Dr.Vivekanand Kattimani
Mobile No: : +91 9912400988

EmailWebsitedrvivekanandsk@gmail.com
www.naturalbioceramics.com
87

88

Startup Name

Product/Technology

Neontram Pvt. Ltd

A neonatal anti-sore bed

Present stage of Development
Validation stage (TRL-6)

Unique Selling Point: The designed product is the only neonatal bed in theworld that can be used for prevention of pressure ulcers.
Product Positioning: There are approximately 18,000 neonatal beds available
in NICU as per the data of 2021. The recommended NICU bed strength per
million population is 30. The population of India is 140 Cr. Hence, 42000
neonatal beds are required in India. On average, each NICU would have about
10 beds, which gives us 4200 NICUs in total in an ideal state. This productperfectly fit into the NICUs of India

Geographical Region Targeted:
NICUs and PICUs of hospitals
in all over India.

National/Societal relevance: According to UNICEF, every day 67,385 babies
are born in India, that's one-sixth of the world's childbirths. Therefore, thisproduct has huge demand in Indian hospitals. The Government of India has
been addressing the issue through its National Health Mission NHM program
by conceptualizing and providing many rural and urban districts now withspecial newborn care units with provision for at least secondary-level Care.
As per our back-of-the-envelope calculation, there are approximately 18,000
neonatal beds available in NICU till 2021. The recommended NICU bed
strength per million population is 30. The population of India is 140 Cr. Hence,
42000 neonatal beds are required in India. On average, each NICU would haveabout 10 beds, which gives us 4200 NICUs in total in an ideal state. NICUs in
India will get benefitted from our product. It will also improve the quality of
neonatal care in India

Units sold:0

Cost:8000 INR (Approx.)

IP Status:
Not applied yetyyMajor Achievements(including awards):
BIRAC BIG-19 Award
Best Poster Presentation
NBRCOM 2021, SYBS India

inImport Substitution: Currently, there is no bed that is used for the preventionof pressure ulcers. Therefore, no such product is imported to India. Therefore,
this product will be major player in India as well as other countries
Export Potential: Globally, newborn health is now considered a high-level
national priority. Adequate and trained manpower is the backbone of NICU
care and the key to better outcomes. This product will reduce the workloadon overburdened nursing staff and will ensure that the rate of occurrencesof bed sores will be diminished. We developed a unique mattress suitable for
NICUs. There is no such product in the market that can be a competitor of our
product. Therefore, there is a huge potential for this product in other countries
as well. Our target market is India and later we may also export.
Product Picture

Contact detail

Mobile No: : +91 9078825885

EmailWebsitehttp://neontram.com/
89Startup Name

Product/Technology

Netraum Ayurveda

Netram Anjan Reverse Cataract without Surgery

Unique Selling Point: Result in 5 Minutes
Product Positioning: Already on Flipkart, and Amazon.
National/Societal relevance: 285 million people are visually impaired in theWorld (World Health Organization) 39 million are blind. WHO predicts that 35
million Cataract operations will be performed in 2023 if the current trend isfollowed

Present stage of Development
Pre-Clinical Successfully Completed(Product Manufacturing from 3rdParty & started marketing)Geographical Region Targeted:
Pan India
Cost:

Import Substitution: 100% Made In India, No import
Export Potential: 285 million people are visually impaired in the World (World
Health Organisation)
Product Picture

500/-

Units sold:
50,000IP Status:
1 Trademark Approved, 2 Applied

Major Achievements(including awards):
Best Start-up Award by a-Idea in 2019

Contact detail

90

Mobile No: : +91 9713862555

Websitehttps://netram.in/Startup Name
Nutrixeric LLP

Product/Technology
Dehydrated indigenous highly nutritious products of Northeast
India, turning unutilized portions into valuable by-products.

Unique Selling Point: Pocket-friendly healthy products without additives andpreservatives.
Product Positioning: We position our product concerning the target audienceas:
1. Health-conscious individuals who are looking for easy and convenient
healthy food options in metropolises and cities throughout the year.
2. They are lightweight and easy to store, making them an excellent choicefor travellers and hikers.
3. Industries, that use dehydrated vegetables and herbs as raw materials.
National/Societal relevance: Our approach will benefit 3 different
segments:(1) Farmers (2) those involved in the rest of the food system (e.g.,
processing, manufacturing, food service, and retail); and (3) Consumers.
Furthermore, by utilizing unconsumed or unused portions, we can alleviate
waste and create a sustainable society.
Export Potential: The global fruit-vegetable processing market is forecast
to grow by 7.95% between 2022 and 2029. A report indicates that Northeast
exported agricultural products worth over Rs 1,800 crore to different
countries last fiscal year, with Assam exporting the most, over Rs 1,700
crore. Consumption and demand for convenient food are increasing globally,
indicating the products' potential.

Present stage of Development
TRL 6
Geographical Region Targeted:
Northeast Region of India.
Cost:
20- 100 Rs per packet (Different productcomes with different pricing.)

Units sold:1550 packets

Major Achievements(including awards):
Selected and awarded seed fund underIshanyas 3.0 "Innovation & Agrientrepreneurship" of RKVY-RAFTAAR
by the Department of Agriculture &Farmers Welfare, Govt. of India, New
Delhi.

Product Picture

Contact details

Mobile No: : +91 8486794040

Websitewww.nutrixeric.com

91Startup Name

Product/Technology

ONEOMICS PRIVATE LIMITED

Saliva Collection Kit

Present stage of Development
Pre-Commercialization

Unique Selling Point:yEasy, fast and non-invasive: sample collection methodyAffordable price compared to existing saliva collection kitsySaliva Preservation Solution – stabilizes buccal cells and white blood cells
found in saliva over 1 year at Room Temperaturey

Kids and Old age people can be diagnosed from homeyExtremely useful to study oncogenesis and tumor progression, especiallyin Oral CanceryGeographical Region Targeted:
Pan India and Overseas
Cost:
INR 500 / Kit

used for genetic testing

Product Positioning:
National/Societal relevance: This Kit can be used to collect the cheek saliva
easily (Split), non-invasively and painlessly. Hence kids and age-old peoples
can diagnose without any trouble.
Export Potential: Huge export potential especially, Singapore, South Korea,
Dubai and Taiwan.

IP Status:
App No. 202141054882, 26/Nov/2021,
India
Title: Saliva Preservation compositions
and processes thereofyyyProduct PictureyyContact details

92

Email

sales@oneomics.in

Websitehttps://oneomics.in

Major Achievements(including awards):
Recognized by Startup India
ISO 9001:2015 Certified Company
DST-Nidhi Prayas grant of 9.9 Lakhs
for development of qPCR based
Mucormycosis Diagnostic Kit
TANSEED 4.0 award worth 10.0
Lakhs from TamilNadu Startup andInnovation Mission (TANSIM)
Innovation Voucher Programme
award of 10.0 Lakhs from EDII,
TamilNadu for Development ofSaliva collection kit for Oral Cancer
diagnosis

93Startup Name

Product/Technology

Panakeia Medisys Pvt Ltd“Pisces” Anaesthesia Workstation

Unique Selling Point: An Indigenously developed Anesthesia workstation
with the latest Technological advances at an economical price, boosting theMake in India initiative

Present stage of Development
Pre-commercialization Stage
Geographical Region Targeted:

Product Positioning: B2C as Potential customer of this product are the
Hospital and Nursing Home owners.

Asia Pacific & Under developed countries

National/Societal relevance: Anesthesia machines have become complex
pieces of medical equipment incorporating a ventilator and various formsof monitoring devices. The Technology related to anesthesia machines has
advanced extensively to make anesthesia safer to administer. The modern
anesthesia machine implementing a closed-circuit system allows for recycling
inhaled gases (i.e., oxygen, nitrous oxide, isoflurane, sevoflurane, etc.),
resulting in a significant reduction in environmental pollution. Our workstation
is integrated with the latest advances in this technology, creating great importsubstitution and export potential.

5.50 lakh + GST

Import Substitution: By 2026 the Indian Anaesthesia Machine market will be
about 350 Crore. About 90% of the device category is imported from Chineseand other markets. This product has the potential to substitute the imported
devices and create a stronger Indian market for the device category

Cost:
Units sold:None as on date

IP Status:
IP filing is in process

Major Achievements(including awards):
NA

Export Potential: The Global Anaesthesia Machine market size is expected
to grow from $ 16.65 billion in 2021 to 18,79 billion in 2022 at a compound
annual growth rate (CAGR) of 12.8% The global anaesthesia market size isthen expected to grow to $28.84 billion in 2026 at (CAGR OF 11.3%. With
the increasing number of chronic illnesses like cataracts, nervous disorder,
muscles repair, oral problem and abdominal issues require surgeries, the use
anaesthesia machine has also increased. So, there is a wide scope of Export
for the product globally.
Product Picture

Contact detail

94

Sourendra
Mobile No: : +91 98113 40469

EmailWebsitewww.panakeia-medisys.com

Startup Name

Product/Technology

PhotoSpIMeDx Private Limited

Smartphone based cervical precancer screening device

Unique Selling Point: We have developed a smartphone-based polarized
fluorescence spectroscopic device. It is compact, portable, minimally invasive,and provides objective and real-time results. Being a standalone device andrequiring minimally trained personnel to operate, it can be easily used in rural
areas where there is a lack of medical infrastructure. Our three fundamental
value propositions are: precancer screening diagnostics, accessibility of ourdevice in remote areas, and affordability to the masses.
Product Positioning: Our solution monitors the storage conditions of bloodbags while it is transported and stored through RFID technology. Using oursolution we will be able to provide data regarding vein to vein that is fromdonor to patient along with end to end tracking and traceability that is madeavailable for Public and Private Hospitals to ensure safe and quality blood.
National/Societal relevance: Cervical cancer kills one woman every eightminutes in India, with the country accounting for about a fifth of the global
burden. Also, the conventional techniques currently in practice are timeconsuming, expensive, limited in either their sensitivity or specificity, anddependent on the examiner’s subjectivity. So, there is a need for devices thatare affordable, accessible, accurate, and minimally invasive. Our polarized
fluorescence-based device is effective in early diagnosis with objective andreal-time analysis. Hence, it can go a long way in improving the healthcare of
the female population of India
Import Substitution: India has a huge market potential for medical devices
but still it depends heavily on imported devices to meet the domestic demand.
These imported devices, apart from being costly, may not be suitable for
Indian hospital conditions or the healthcare infrastructure. Our indigenously
developed diagnostic device can create huge market impact since it has thepotential of filling in the gap created by the lack of affordable diagnostic
devices
Export Potential: This device after successful validation and verified by
the authorized body will have the potential to reach those countries which
are lacking better health facilities and awareness about women health. The
device will be able to screen women patients with signs and symptoms ofcervical cancer.

Present stage of Development
The prototype is developed and validated
in-house at IIT Kanpur. Currently multiple
units are being fabricated to be used for clinical validation of the device. Clinical testingof the device is being carried out at various
hospitals in the country

Geographical Region Targeted:
Our device will be of societal importancewhich will affect the cervical cancer cases
and reduce the mortality numbers in the
country. So, our targeted areas are hospitals
and clinics all across the country and alsoreach to rural and far flung areas.

Cost:~ Rs 2,00,000 (hardware cost)
Units sold:zero (pre-revenue stage)
IP Status:
Patent application filed for smartphonebased device for cervical cancer detection:
IPA # 202111006127, Title: “Smartphone
based polarized fluorescence spectroscopic
device for early detection of cervical cancer”.

Major Achievements(including awards):yyyProduct Picture

y

y

y
y

Contact detail

Shikha Ahirwar
Mobile No: : +91 9651605272

EmailWebsitePATH - selected as one of the 12
Winnerof BIG 13 call scheme sponsored by BIRAC,
India.
Patent application filed for smartphone
based device for cervical cancer detection:
IPA # 202111006127, invention title:“Smartphone based polarized fluorescence
spectroscopic device for early detection of
cervical cancer”.
Collaboration project with IIT Kanpur:
Received aid in grant funding ~ 70 lakhs fromDST (Department of Science and Technology).
Published a research paper titled “Asmartphone-based 3D printed prototype
for polarized fluorescence collection fromhuman cervix” in Optica publishing group.
Published a journal paper titled “Design,
fabrication and testing of 3D printed
smartphone-based device for collection of
intrinsic fluorescence from human cervix” inScientific reports.
Winner of BCIC Emerging Stars Awards,
2022.
Winner of I-HUB Grant challenge 2022.

ceo@photospimedx.com
https://photospimedx.com/
95

96

Startup Name
Primary Healthtech Pvt Ltd

Product/Technology
IOT-enabled Point-of-care Blood testing Device foraffordable and accessible healthcare powered AI/ML algorithms
Present stage of Development
Pilot testing of device

Unique Selling Point: NA
Product Positioning: NA

Geographical Region Targeted:
All across India

National/Societal relevance: Symptoms of majority of non-communicablediseases are detected at later stage. Our innovation, the Multi-Diagnostic
Device ‘Mobilab’, is capable of analyzing different parameters for diagnosis
of Kidney, Liver, Pancreas, Heart problems, etc. through the proprietaryinnovations in nanotechnology, electronics & materials. This is easy-touse product, self-guided UI and AI-engine makes it the perfect solution forproviding decentralized low-cost comprehensive healthcare to low-income
households even at the remote-locations.

Cost:~25000/device

Units sold:
Pre-Revenue Stage

IP Status:

Import Substitution: Yes

5 Patents filed

Export Potential: Affordable Portable POCT device has huge demand acrossglobe .
Product Picture

Contact details

Mobile No: : +91 9315824671/
9650788728

Major Achievements(including awards):
1.

SASACT grant by MEITY, GOI.

2.

CHUNAUTI grant by MEITY and
STPI.

3.

Incubated and funded under invent
program at KIIT TBI.

4.

Recipient of DBT-BIRAC BIG grant.

5.

SOCIAL INNOVATION LAB disburse
grants by CITI

EmailWebsitewww.primaryhealthtech.com

97

Startup Name

Product/Technology

Primogen Biotech Private Limited

TrimoPrim: DNA, RNA and protein simultaneous isolation kit

Unique Selling Point: The kit (TrimoPrim) can simultaneously isolate pureform of genomic DNA, total RNA and protein from a single biological sample.
TrimoPrim is the first “Make in India” product of its kind. The protocol developed
is rapid, efficient and user-friendly. And the price of the kit is economicalcompared to similar kits available in market.

Present stage of Development
Validation stage at TRL 6
Geographical Region Targeted:
India and abroad
Cost:

Product Positioning: B2C: Research Laboratories.
National/Societal relevance: It is known fact that intervention of molecular
tools like molecular markers, molecular diagnosis, transgenics, etc will play
an important role for human welfare. Lots of molecular biology work need
to be performed in coming years for genomic and proteomic studies. For any
molecular biology work we need to have good starting molecules like DNA,RNA or protein with quality yield, integrity, stability, and purity of samples.
The best part is that this kit is the first “Make in India” product of its kind.
Thus promoting “Make in India” concept; generating revenue and creating job
opportunities for the young generation.

10,000 INR (Tentative)

Units sold:
NIL
IP Status:
Indian Patent filed (Application No.
201831000081 Dated: 01.01.2018)

Import Substitution: Since our product is first of its kind in India therefore, it
has a potential to substitute similar kits imported from abroad.
Export Potential: TrimoPrim can be a strong contender to compete withsimilar kits available globally.
Product Picture

Contact details

98

Mobile No: : +91 7896881168/
7896307821

WebsiteDeveloping shortlyProduct/Technology

Startup Name
Prognostics In-med Pvt Ltd

Neuroshield: a) Creating and annotating a manually/semiautomatically segmented database of Indian brain MRIs. (b)Designing and validating a deep neural net for automatedsegmentation

Unique Selling Point: The present stage of Development: Commercialization

Present stage of Development
Commercialization

National/Societal relevance: IQuantification of brain structures using theIndian brain template enables neurologists to use an evidence-based medicine
approach for neurodegenerative conditions while referring to the MRI of thebrain.

Geographical Region Targeted:
India

Export Potential: We are targeting exports in 35 countries and have started
with discussions with distributors and aggregators. We are also US FDA 510k
pending and post USFDA we plan to launch in both developing and developed
markets

Cost:
500
IP Status:
Mark: NeuroFlo CLINICAL AI AT WORK
(Logo) Owner: In-Med Prognostics Inc
DLG. Ref.: INME-002-00AST Intl.
Class: 009yyyContact details

Mobile No: : +91 9764445205

WebsiteMajor Achievements(including awards):
GE Edison Cohort II in 2021
BIG Innovation Fund in 2019
Microsoft Startup Program 2022

http://in-medprognostics.com/

99

Startup Name

Product/Technology

ProPlant Foods Pvt Ltd (ProMeat)

Plant-Based Meat Alternatives using Plant sources and Cutting
Edge Technology like Wet-Extrusion and Electro-Spinning Methods

Unique Selling Point:y Products with 60% Protein content compared to animal meat.
y Made with Plant-based fat (Good fat).
y Complete Micronutrients and Macronutrients compared to animal meat.
y No Off-note Issue.
Import Substitution: Yes
Export Potential: Yes

Present stage of Development
MVP [Minimum viable product]
Geographical Region Targeted:
We plan to target all Cities in India,
starting with the major metropolitans
including Delhi, Gurugram, Mumbai, andBengaluru

Cost:
B2B - 800-900 per kg / D2C - 12001300 per kg.

Product Picture

Units sold:NA
IP Status:
Filed
Major Achievements(including awards):
We won the India Smart Protein
Innovation Challenge (Plant-Based
Meat Category) by Good Food Institute,
India in Dec 2020 2. We received a
grant from the Govt Of India and Proveg
International.3. We emerged in the Top
3 startups globally in the Innovation
Challenge (Improving Plant-Based Meat
Technology Category) by Unilever in
Feb 2021. 4. We emerged in the Top
10 teams globally in ReThink Protein
Challenge 2 in Plant Protein Innovationsin April 2021. 5. We recently won theEnvirocare Green Awards 2021 among
65+ teams globally.Challenge 2020
Nasscom t4g - Technology for good Finalists 2019

Contact details

100

Mobile No: : +91 8724057453

Websitewww.promeat.inStartup Name

Product/Technology

Quantrello Digital Private Limited

Borlaug Web Services® (BWS)

Present stage of Development
TRL - 7

Unique Selling Point: Immutable data, fair governance & accountability;
generation of test reports on blockchain to certify honey; premium forcertified and traceable honey; the information is shareable and visible to any
stakeholders

Geographical Region Targeted:
India, Africa, EU

Product Positioning: We are currently creating Beekeepers Collectives andestablishing a standard for responsible sourcing of honey. In the process, weplan to build a Honey Subscription Model, a true farm-to-fork model, where
the Apiaries can be tokenized via
blockchain, and adopters/subscribers (businesses) can subscribe to a share of
the harvest or hive products directly from the apiaries. This will enable farmers
to pre-sell their produce at the beginning of the harvest and Customers, on theother hand, will get access to pure unadulterated honey directly from farms
National/Societal relevance:yEqual access to economic and social benefit schemesyReduce wastage and carbon footprintyCreate fair opportunities and wider market accessy
Food safety, credibility, and trust.
ySecure data managementyCompliance with EAC-PM Report for verifying source to prevent
adulteration
Import Substitution: N/AExport Potential: Scientifically produced honey with test reports, trace
reports, and trade reports on blockchain to reach global markets

Cost:
INR 200000

Units sold:
N/A
IP Status:
IP filling is in process. We are working
on the IP for our open source Borlaug
Network blockchain with an IP Attorney
firm

y

y

Product PictureyContact detail

Mobile No: : +91 7980941562

WebsiteMajor Achievements(including awards):
Winner of Sustainable Agri Award
2022 for Driving Sustainable
Agriculture & Food Security from
IGCC at CII Agro Tech, Chandigarh.
Winner of SDG Impact Accelerator
andUNDP-funded
DigitalAgriculture Implementation in
Uganda for coffee sustainability.
(2021)
Featured in impact city and inc42

www.borlaug.ws

101

Startup Name

Product/Technology

Reinste Nano Ventures Private Limited

Warrior Anti Viral & Antimicrobial Coatings

Unique Selling Point: Warrior TM Coatings are developed after rigorous
R&amp;D by a 11-year-old Nanotechnology based company which has ahistory of service in nanotechnology for health care sector. Research of thisproduct was overlooked by DBT (BIRAC), Govt. of India and all certifications
are from Government accredited labs. The product is proven 99.9% effective
against SARS CoV-2 and other disease-causing viruses, fungi &amp; bacteria
Product Positioning: Available in market
National/Societal relevance: Warrior Coatings are Nanotechnology
based coatings which are 99.9% effective on wide range of pathogenic
Microorganisms including Virus. The product is tested &amp; certified fromdifferent government bodies like National Forensic Science University, Shreechitra trimul Institute. The product is Non toxic to humans and has 99.9%
killing rate of pathogenic microbes. The coating works 24*7 and neutralizes
the microbes which come in contact with this coating. The Coatings are
extremely cost effective and are ideally suited in wide situations, surfaces andenvironments and are available for all kind of surfaces
Import Substitution: The product is a great substitute for the antimicrobial
paints, coatings, or even other disinfectant solutions imported currently in
India which are used in hospitals and other labs

Present stage of Development
Pre Commercialisation
Geographical Region Targeted:
All over the Globe
Cost:
Ranges between
Rs 0.5 – Rs. 150 per Sq Ft

Units sold:
50 L
IP Status:
We are planning to file patent

Major Achievements(including awards):
Textile Industry is manufacturing
antimicrobial mask using our productand technology.

Export Potential: The Warrior antiviral product is tested from Government ofIndia laboratory which states that the product is 99.9% effective and safe forhumans as well . The product has great potential to be exported.
Product Picture

Contact detail

102

Mobile No: : +91 9810662669

EmailWebsitewww.hiyka.com

Product/Technology

Startup Name

Valorization of Agro waste for converting into bio active compounds/
bio-fuels/bio-chemicals using biotechnology process with microbial /enzymes in dark fermentation technology.

Renergizr Industries Pvt. Ltd.

Unique Selling Point: NanoTechnology approach to Encapsulate beta carotene
to increase its stability and atomizing with CNTs(carbon nanotubes) for better
isolation. We will use plant based citric acid solution (50 wt% volume with
deionized water) to soak all waste to ensure pectinase and other enzymes/
compounds get inactivated prior to extraction process.

Present stage of Development
MVP and now in process ofcommercializing
Geographical Region Targeted:
North Indian states

Product Positioning: High value platform green chemicals and biofuels .
National/Societal relevance:
1.

2

3

Cost:
Rs 1500 per Kg

The use of waste for the production of natural beta carotene will prevent
emission of 600,000 cubic meters of greenhouse methane gas from 1Kg
of natural beta carotene production which is an important step towardsustainable development.
Purchasing the discarded/poor quality of nendran banana fruit post
harvest from farmers will provide additional income of Rs 25 per kg
which will help in their economic development/financial upliftment
but also help prevent greenhouse gas emissions to ensure cleaner andgreener environment.
Fruit waste utilization increases Human development index(including
key dimensions of human development: a long and healthy life, being
knowledgeable and have a decent standard of living) by 10% based on
the fact that additional income generation for fruit waste generators
which will be passed on to the fruit vendors and farmers with increased
standard of living along with increased health & age of consumers
who are utilizing these natural bio active compounds, greenhouse gas
emissions reduction of around 6% to 8% by utilization of fruit waste.

Units sold:
120 KgIP Status:
To be filed
Major Achievements(including awards):
BIRAC Sparsh fellowship grant funding,Schaeffer India Social Innovation
Fellowship Award at national level

Import Substitution: Yes for synthetic chemical based pectin which is Rs 500
crore market
Export Potential:
Packaging and chemical, Food and beverages,
pharmaceutical industries.
Product Picture

Contact details

Emailrenergizr.industries@gmail.com
103

Startup Name

Product/Technology

REVY Environmental Solutions Pvt. Ltd

Anaerobic Granulated Sludge
Present stage of Development
Pre-commercialization

Unique Selling Point: An Innovative effective solution for organic waste /waste water conversion to recover Biogas and reusable water

Geographical Region Targeted:
All India

Product Positioning: Our Solutions will also act as a very cost-effective
solution for High Rate Anaerobic Digesters (e.g UASBs) commissioning as wellas will work as medicine for all sick units of STPs & ETPs. Once the existing
anaerobic digesters as well as upcoming anaerobic digesters start using
granulated sludge, their operational functionality will improve drastically, andmuch more liquid waste can be treatment in a quicker way for its re-use.

Cost:
Rs 250/ Litre

Units sold:300 Litres

National/Societal relevance: India has 17% of world population and only
4% of world fresh water resource. Another major issue is fresh water bodies
deterioration due to untreated sewage and effluent discharge. 62,000 MLD
sewage is generated but no more than 18,883 MLD (21%) of sewage isactually treated. Out of 816 STPs, only 522. Water for irrigation is expected
to reduce by 25% by 2050. Thus, there is an urgent need for efficient water
resource management through enhanced water use efficiency and waste
water recycling.
India’s quest for energy security and sustainable development rests a great
deal on the ability to tap energy from the renewable sources. Our per capita
average annual freshwater availability has reduced by 3.5 times since 1951.
It is expected to further reduce by 4.5 times by 2050. Insufficient capacity of
waste water treatment and increasing sewage generation pose big questionof disposal of waste water. Problem can be mitigated by adoption of costeffective eco-friendly technologies for waste water treatment
Import Substitution: Yes

IP Status:
Granted In India, USA, South Africa;
Under Review in Europe and Malaysia

y
y

y
y

Export Potential: YesyProduct Picture

y
y
y
y
y
y
y
y

Contact details

Mobile No: : +91 9824519652

Emailmail@revy.co.in /Websitehttp://www.revy.co.in/

y
y

y

104

Major Achievements(including awards):

WinnerIndia-Israel
Innovation
Challenge 2017 organised by Invest
India
Finalist Smart Fifty Award conferred by
Department of Science and Technology,
Government of India and IIM Calcutta
Innovation Park
Felicitated for "Success Story Award"
during India International Science
Festival, 2018.
Winner of “Swachch Bharat Grand
Challenge” organized by Start-up India
Winner of “Integrate to Innovate
Challenge” organized by Invest India.
Winner of YESSCALE under cleantech
category and is being funded by Villgro
BIRAC-TiE WInER Award 2019 by DST,
GOI.
Winner award in the ICC start up pad at
Bengaluru.
Winner of ASSOCHAM Start-up
Launchpad, Pune.
Winner of Social Alpha Urban Liveability
Challenge,2019
under
Cleantech
categoryAwarded as ‘Frontrunner’ in Cleantech
sector by ITC Go Global Awards 2021
Winner of National Start Up
Awards 2021 under environmental
Biotechnology
Conferred Global Technology Innovation
Award in MSME Category by GITA
Dr Vanita Selected for ‘Women in Biogas’
By World Biogas Association, London.
Dr Vanita Selected for BRICS Mulan
Award, Conferred by BRICS China under
BRICS Women’s Business Alliance
Initiative.
Finalist GUSEC Techcelerate Program

105

Product/Technology

Startup Name
RONCOV Diagnostics and Therapeutics Pvt. Ltd

Targeted Radiotracer for Diagnosis (99mTc) and
Treatment (177Lu) of Prostate Cancer

Unique Selling Point:y Novel and indigenous, no violation of international copyrights
y The products are cost effective, accurate and selective
y Indigenous technology to diagnose PCa and treat incurable mCRPC
y No false positives, precise, inexpensive, and non-allergicy No collateral damage to healthy tissues, and minimal side effects
y Availability of specialized experts for applications of radiopharmaceuticals
in human clinical trial during last 10 20 years using targeted technology
Cost:MarketDiagnostics (PET,
SPECT 68Ga, 99mTc)

Therapeutics (177Lu)

India (50%)

17,250 PCa x INR 5,000/x 2-Scan = INR 172,500,000/-

17,250 PCa x INR 10,000 x
5-session =INR 862,500,000/-

141,425 PCa x USD 500 x 81 x
2-Scan = INR 11,455,425,000

141,425 PCa x USD 500
x 81 x 5-session = INR
28,638,562,500(1 USD = 81 INR)

International(10%)

Present stage of Development
Preclinical Development
Geographical Region Targeted:
India and International
Units sold:
Preclinical Trials
IP Status:
Venkatesh C., Sengupta S., Krishnan
M.A., Pandit A. (2018), Small molecule
inhibitors for early diagnosis of prostate
specific membrane antigen cancers andneurodegenerative diseases (Application
No. 201821044594, Indian Patent)
Venkatesh C., Sengupta S., Krishnan
M.A., Pandit A. (2019). Small molecule
inhibitors for early diagnosis of prostate
specific membrane antigen cancers andneurodegenerative diseases (Application
No. 16695851, USA Patent)

Product Positioning: HealthCare
National/Societal relevance: Our product aims to deliver early diagnosis
and therapeutic treatment for prostate cancer. The molecule is composedof targeting ligand AAPT followed by peptide linker and radioactive isotope
as 99mTc for diagnostic and 177 Lu for therapeutic, which binds with PSMA
receptor overexpress on the PCa
Import Substitution: PSMA-617 PCa Diagnostic Agent

Diagnostics (PET, SPECTGa, 99mTc)(No. of Patients)

Therapeutics(177Lu)India (50%)

17,25017,250International (10%)

141,425

141,42568yyyExport Potential:
Medical Hospitals,
International Cancer Centers

Major Achievements(including awards):
PATH - selected as one of the 12
startups for improving primary
healthcare in LMIC.
Finalists in Qualcomm Design India
Challenge 2020
Nasscom t4g - Technology for good
- Finalists 2019

Product Picture

Contact details
106

Dr. Venkatesh Chelvam
Mobile No: : +91 7898514502

Emailcvenkat@iiti.ac.in

Websitehttp: people.iiti.ac.in/~cvenkat/

Startup Name

Product/Technology

RUT3

Rut3

At Rut3 makes you Safer, Comfortable and Efficient, by integrating suspension
inside the rim i.e. suspension wheel. We aim to transform our mobility sector
into a safer way of commuting. Today people travel using various modesof transport but safety and comfort is their priority. They aim address thesame in a very cost effective way, reducing back injuries, saving lives during
accidents, and making the vehicle efficiency better.

Present stage of Development
The product is deployment ready in
the Indian Wheelchair Market and weare looking for long term vendors,
soon our Bicycle prototype will be
readyUnique Selling Point: The product is a rim with suspensions inside it, replacing
the spokes. The product is multi-axis suspension system which provides
comfort [reducing back injuries], Safety [multi-axis helps during accidents totake impact from the front], Efficiency [forward movement helps to reduce
the efforts to drive]. We have replaced the spokes by the suspension system
inside rim, which when travels over uneven terrain the flexible ellipse expand
and compress providing suspension action and when they get back to theirinitial position it provides forward movement reducing efforts to ride

Geographical Region Targeted:
South Asian, Western, Middle East
Cost:
B2B cost ranges from 4500/pair ofwheels to 18000/pair of wheels
Units sold:Pre-order of 4000 Wheels

Product Positioning: Product enhancing Safety, Comfort and Efficiency inWheelchairs [Also creates high social impact], and Bicycles. With pipeline
products in Two-wheelers, Toys , Drones and Space market.
National/Societal relevance: The solutions are initially targeted towards
Wheelchairs, Bicycles. Majority of people using these mobility’s will be affected
directly by the innovation. The innovation creates a massive impact on theperspective of physically challenged towards mobility and their movements
on every terrain. The innovation will drive the automobile industry into a
new generation of safety wheels, reducing risk of losing life, inducing backinjuries, and also making the vehicle efficient overall. The product is unique as
it combines wheel + suspensions in single product and addresses issues likespine/back injuries, safety during accidents.
They make the physically challenged capable of travelling over any terrain
Import Substitution: They will create a type of wheel hub in India, which will
create new exports and also replace/substitute other advance technologies
in wheels
Export Potential: Already in talks with International players with very highvolume, exporting majorly to Europe.

IP Status:
Granted

y
y
y
y
y
y
y
y
y
y
y
y
y

Major Achievements(including awards):
Prosus Assistive Technology Winner[1st Place Overall India]
Utility Patent Granted 2022
MEITY EIR Grantee- 2022
ATAL Innovation grantee -2021 –Top 26 in India- By NITI Aayog GOIBAJAJ CSR-2020
Industrial Design Granted-2021
NIDHI EIR Fellowship-2019
Utility Patent Published 2017
Vibrant Gujarat Award
MIT Vishwa Young Innovator
Dexterity Innovation AwardYUKTI Innovation Award
Covered by Media, and Newspaper

Product Picture

Contact detail

Mobile No: : +91 7798626714

Emailhttps://linktr.ee/rutthree

Websitewww.bagmo.in
107

Startup Name

Product/Technology

Ryot Agro Private Limited

Automatic Cocoa Bean Separating Machine

Unique Selling Point: Gives more output than competitor product and priceis less
Product Positioning:y Machine will separate 300-350 kg of cocoa beans in 1 hour for large
machine & the small machine will separate 100-150 Kg of cocoa beans in
1 hour, thereby reducing the time requirement for cocoa bean separation.
y Machine can be operated by the farmer alone, thereby reducing the labour
cost comparing with manual process of cocoa pod breaking & cocoa bean
separation.
y Machine is provided with protective covers, so there is no chance of being
injured.
y Less chances of faults, since the machine is working fully mechanically.
National/Societal relevance: There is huge scope among cocoa farmers in
Kerala, Tamil Nadu, Karnataka and Andhra Pradesh. vThis machine will help
the farmers to reduce labour cost, time and energy
Import Substitution: Currently no such machine is available in Indian Market

Present stage of Development
Prototype Developed
Geographical Region Targeted:
Kerala, Tamil Nadu, Karnataka, Andhra
PradeshCost:
Rs 40,000 for Small machine andRs 80,000 for Large Machine

IP Status:
Filed Design Patent, Patent Application
No: 347614-001yyMajor Achievements(including awards):
Won BIRAC BIG grantee,
Won NIDHI Prayas Grant

Export Potential: Currently one company china is manufacturing one suchmachine. But comparing with them ours is priced less and output is more.
Product Picture

Contact details

108

Ajith Mathew
Mobile No: : +91 9048947909

Emailajithmathewthakidi@gmail.com

Websitehttps://ryotagro.com/

Startup Name

Product/Technology

Samasti Health Technologies Pvt Ltd

Svasthya

Unique Selling Point: Effortless User Experience with Medical Grade ClinicalAccuracy and Context Assessment

Present stage of Development
TRL 7, Pre-deployment trials at
hospitals

Wireless, Cuffless, Ambulatory assessment with real-time alerting for timely
medical intervention, care co-ordination and delivery at any place
Product Positioning: The cloud based bio-informatics platform provides
clinical decision assistance to physicians to assess health, triage and provide
care remotely. As a GP / virtual assistant we send EWS and alerts to specialist
physicians only on a need basis. They help hospitals extended services
beyond hospitals in a clinical data driven, pay per use scalable model without
requirement of capital investment and develop patient stickiness ultimately
increasing foot falls, improving capacity utilization, health equity and revenue
possibilities at the same time.
National/Societal relevance:y
Svasthya enables remote health delivery to a population in rural or urban
settings by providing,yRemote healthcare and triageyPopulation health statisticsyPrimary health screening.
Import Substitution: Multiparameter monitors and Remote care. Indian
patient monitoring market is valued at USD 1,369.56 million and growing at
CAGR 9.39%
Export Potential: Svasthya’s TAM 47 million subscribers in India, US, UK +Europe, Middle East + North Africa geographies with a market potential of
USD 2.5B.

Geographical Region Targeted:
India, Europe, US and Japan
IP Status:
Patent under ISR

y
y
y
y
y
y
y
y
y
y
y
y
y
y

Product PictureyContact detail

Avinash Babu M
Mobile No: : +91 9886350754

Major Achievements(including awards):
Product launched by KBITS.
Product launched at Bengaluru Tech
SummitSwedish Innovation Award for “Lifesaving from distance” along with
our Swedish partners
Part of KSAPBIO50, BioNest, SEED
Customers
Partnership MoUs
Clinical trials completed at
Jayadeva Institute of Cardiovascular
Sciences and Research
Sagar Apollo Hospital
BGS Global Institue of Medical
Sciences
Clinical trials in discussion
Shankara Cancer Care
St John’s Hospitals
PHC
implementation
withGovernment Of Karnataka
Pilot
implementationatShivagange PHC in progress –Workflow automation and Datainteroperability

Emailavinash@svasthyahealth.com

Websitewww.svasthyahealth.com

109

Startup Name

Product/Technology

SAVEMOM PRIVATE LIMITED

AlloTricoder: An IoT based kit that measures 8 vital parameters andsecurely sends the data over to the cloud for analytics.
AlloWear: A smart wearable device that continuously tracks activity
and sleep cycle reminds the patient to take medicines and do theirscheduled check-ups

Unique Selling Point: Devised an easy method to collect critical maternal
data digitally. Products can be connected with a mobile application throughwhich all the collected data can be stored and used for providing homebased antenatal care, screening of high-risk pregnancy as well share thedata with their healthcare providers. Innovation has four major customers, aPregnant mother and her husband, a health worker, Doctor, and a Hospital/
District administrator. Products has been integrated with esanjeevani Tele
consultation platform by Government of India to provide the real time vitaltracking during the video call.

Present stage of Development
TR9 Successfully completed the Clinical trail with Andra pradesh Government as part of Jancare Challenge
programGeographical Region Targeted:
Western gaud remote villages & PHC

Product Positioning: NA

Cost:
INR 30,00,000

National/Societal relevance: The product deployed in western ghat tribal
community working with three state Government. Successfully monitored
more than 36,000 pregnant mothers through our platform and provided
2,90,000 home based antenatal care for mother.

Units sold:100

Our innovation become a design thinking case study at Harvard Business
SchoolIP Status:
Granted Patent No : 355555-01

Product Picture

Major Achievements(including awards):
SAVEMOM Become a Design
Thinking Case Study in Harvard
Business School
Winner of NASSCOM HealthInnovation challenge 2.0
Finalist of the Healthy Mom &Healthy Baby Innovation challengeorganized by Parview view HealthUSA.
A case study published in Yale publichealth USA
Winner of SIHI Award from TDR
World health organization for Social
Innovation health initiative
Winner of Jancare Health innovation
challenge
Winner of Anjani Mashker inclusive
innovation Award 2020

y
y
y

y
y
y
y

Contact details

110

Mobile No: : +91 8095207092

Websitehttps://savemom.in

Startup Name

Product/Technology

SCYLENE TECHNOLOGY AND LIFE SCIENCES PVT LTD.

HealthFillz Vegan Plant-Based Protein

Present stage of Development
Commersialization

Unique Selling Point:yHigher Mix abilityyEasy absorption and digestion NaturalyVegan and Gluten-free Affordable

Geographical Region Targeted:
India and European Regions
Cost:
749 INR for 350 grams

Product Positioning: Hospitals, Pharmacies and Wellness centers.
National/Societal relevance:yCruelty-freeySustainable Environment HealthyyReducing Protein Deficiency

Units sold:
560
IP Status:
Applicable for trade secret.

Import Substitution: Pea protein imported from Poland

Major Achievements(including awards):
Startup India and Startup Odisha
Recognition

Export Potential: Rising demand in European Market
Product Picture

ProductPicture:

Contact details

Mobile No: : +91 7077560541

Email
Websitescylene.pvt.ltd@gmail.com
www.scylene.com

111

112

Startup Name

Product/Technology

Sengathalibiofiber Pvt Ltd

Banana Sap & Liquid Fertiliser

Present stage of Development
Ready to Market

Unique Selling Point: Farmers
Product Positioning: To the End customer

Geographical Region Targeted:
Banana tree cultivation area

National/Societal relevance: National importance project
Import Substitution: Reduction of import chemical fertiliser

Cost:
Vary with Quantity

Export Potential: Very good export potentials

Units sold:

Product Picture

We have sold one machine and 5000
litter of banana sap

IP Status:
In Process
Major Achievements(including awards):
We have received IISF 2017 Award at
Lucknow

Contact details

Mobile No: : +91 9443110344

Websitewww.bananasilkfiber.com

113

Startup Name

Product/Technology

Shankaranarayana Life Sciences LLP

ROBAC: Robotic Biomolecule & Cell separator

Present stage of Development
Product Launched

ROBAC is capable of separating biomolecules like protein, RNA, DNA or otherbiomolecules and different kinds of cells. ROBAC has additional flexibility toadjust experiment conditions based upon custom requirements of the user.

Geographical Region Targeted:
South India

Unique Selling Point: Hospitals, Clinical Laboratory and Port Of Entry.
Product Positioning: Diagnostic laboratory, Research Laboratory, Academics
and Manufacturing company.

Cost:
Rs. 4 Lakhs

National/Societal relevance: All countries are having adequate testing facility,
but is not economical and accessible to maximum number of populations. In
consideration, the ROBAC device can be installed at any hospitals, clinicallaboratory and port of entry. It would be reliably helpful in diagnosing patients
within a shorter time, and is very useful in country like India and throughout
the world.

Units sold:
10
IP Status:
TRL-9

Export Potential: 100
Product Picture

y

y
y
y

Contact details

114

Mobile No: : +91 7022035071/
9483504143

WebsiteMajor Achievements(including awards):
ProgrammableRNA
isolation
device inaugurated by Honourable
Deputy CM of Karnataka Dr. C. N.
Ashwathnarayan
CDSCO approved
PatentApplication
No:202041021570
Running in more than 10 hospitals

www.snlifesciences.com

Startup Name

Product/Technology

SharingMitra Foundation

Web Application

Unique Selling Point: We are reducing carbon footprint along with spreadinghappiness both at the same time
Product Positioning: For the children by the children, Community driven
initiative
National/Societal relevance: We are reducing carbon Footprints andspreading happiness among under privileged children

Present stage of Development
Product Ready, Traction mode
Geographical Region Targeted:
Started from Nagpur andspread across India
Cost:
Zero cost and that is the USP

Import Substitution: Not relevant

Units sold:

Export Potential: Not relevant

Reduced more than 200000 (eq) Carbon
Footprints by putting resources to reuse

IP Status:
Not relevant

Major Achievements(including awards):
Young Innovator Award 2022- Finalists
2019

Contact detailAshfaq Ashraf
Mobile No: : +91 9324672383

Websitewww.sharingmitra.org

115

116

117

Startup Name

Product/Technology

SMART Home Health care Solutions Pvt Ltd

Urhab, Online Physiotherapy and digital rehab platform

Unique Selling Point: Automated patient compliance and recovery tracking,AI based remote assessment
Product Positioning: Access to top physiotherapists from India.

Geographical Region Targeted:
Across India

National/Societal relevance:yAccess to top Physiotherapists from any part of India,yreduced total cost of recovery,ybetter compliancePhysiotherapists

andimproved

productivityofpatient

andExport Potential: Potential to treat International patients from India

118

Cost:
199/ per day
IP Status:
TBD
Major Achievements(including awards):
BIG award from BIRAC

Product Picture

Contact details

Present stage of Development
Validation

Arun Kumar Ramasamy
Mobile No: : +91 6380069819

Websitewww.urhab.com

Startup Name

Product/Technology

SNRASSYSTEMSBLUEBOX Aquaculture System

Unique Selling Point: Nursery rearing and grow out of freshwater finfish, highvalued fishes and Crabs. Can be used for live fish transportation.

Present stage of Development
Minimum Viable ProductProduct Positioning: End to End Supply chain integration starting with yield
multiplication using BLUEBOX and finishing with market linkage support

Geographical Region Targeted:
UP, MH, KN, WB, BH, TN, NE

National/Societal relevance: Empaneled by National Fisheries Development
board under Pradhan Mantri Matsya Sampada Yojna launched in 2020 where
2.5 Bn USD is infused to solve the demand supply gap of fisheries which 8.5
million tons today. Awarded by Fisheries Secretary of India, CII and WorldBankfor designing Livefish transportation systems using the BLuebox Technology

Cost:
15 lacs

Import Substitution: Yes. 6x cost effective than imported RAS systems.
Export Potential: Yes. Received intents from Middle-east and African andSouth Asian countries.
Product Picture

Contact detail

Mobile No: : +91 7020307244

Units sold:
6
IP Status:
1 granted, 2 filed
Major Achievements(including awards):
NA

Email
Websitewww.snrassystems.com

119Startup Name

Product/Technology

STEAMedu LEARNING PRIVATE LIMITEDSTEAM Education

Unique Selling Point: Learning-by-Doing Programs for 21st century Learners& Educators

Present stage of Development
Revenue generation stage

Product Positioning: Students of all ages and educators of all streams whowant to enhance their learning and teaching through STEAM Education.

Geographical Region Targeted:
GlobalNational/Societal relevance: An amalgamated knowledge of Science,
Technology, Engineering, Arts and Mathematics through experimentation
leading the students of all ages to be part of development of society, country,
and world along with self development. Students also volunteer for Peer
mentoring to impart STEAM Education in underserved community free of costas part of the social outreach programs and served more than 1500 students
so far from rural & remote areas

Regular Program- 45k yearly fee for age
below 10, 125k yearly fee forage above 10
Workshop/Bootcamp fee- 300 to 500
per hour

Import Substitution: The technology aims to provide advance international
STEAM education with open source resources. Learners don’t need to importanything
Export Potential: While the STEAM education system globally is progressing
rapidly, there is a huge gap for STEAM Educators, Alumnae of the program canfill this gap as an export potential of STEAM teachers.

120

Units sold:
40 workshops/bootcamps conductedwith more than 500 students’participation

IP Status:
Logo trademark applied

Major Achievements(including awards):
STEAMEDU received Udyam Veer Award
2019

Product Picture

Contact detail

Cost:

Mobile No: : +91 9555984326

Websitewww.steamedu.in

121

Product/Technology

Startup Name
Swapeco Solutions Pvt. Ltd.

ScrapUncle - An On Demand Junk Selling Platform(App/Website) for India
Present stage of Development
Growth Stage (Revenue Stage)

Unique Selling Point: ScrapUncle is bridging the digital divide in the traditional
recycling business by blending it with technologies like mobile applications,
IOT-based smart weighing scales, analytics, etc.

Geographical Region Targeted:
Delhi NCR

Product Positioning: Received 60k+ signups on the platform. Completed
32k+ pickups in Delhi NCR. Sent ~16 Lacs Kgs of Scrap for Recycling .
National/Societal relevance: Diverting Recyclables from Landfills to
Authorized Recyclers; Training and employing people from the informal sector.

yImport Substitution: Yes
Export Potential: Yes.Studies found that blood supply chain complexities
in developing countries like : expiry time, temperature and transportation
requirements, supply and demand gap etc. Many low income countries stillpractice unbanked directed blood transfusion which can be avoided by having
effective blood supply chain monitoring solutions.
Product Picture

Contact detail

122

Mobile No: : +91 9958455627

yyMajor Achievements(including awards):-Winners of the Urban works
challenge by Columbia University.
Received a $38k grant (~Rs. 30Lacs) for the same.
-Winners of the Mbillionth Awards
South Asia organized by DEF &Facebook-Received Facebook Grant for small
businesses (Rs. 1.5 Lacs)

Emailmukul@swapeco.com

Websitewww.scrapuncle.com

Startup Name

Product/Technology

This Life Matters Pvt Ltd

Ferma Tech Beverages

Present stage of Development
Market Ready

Unique Selling Point: Gut Health and Mind Health
Product Positioning: Super stores and Online selling.

Geographical Region Targeted:
North India

National/Societal relevance: Improving GUT health.
Import Substitution: NA

Cost:
150/-

Export Potential: YES Market is ready.
Product Picture : NA

Units sold:
10,000IP Status:
Applying
Major Achievements(including awards):
NA

Contact details

Abhishek Dhaliwal
Mobile No: : +91 9899048319

Websitewww.ekkomoh.com

123

Startup Name

Product/Technology

Tishyas Medical Device Development Solutions Pvt Ltd

IXanner®

IXanner® enables the capability of comprehensive Eye screening anywherein the world, as it is a battery run, the device is accessible at very remotelocations as well. The device is capable of screening patients for up to 8 Hrs
and can generate the report within minutes. Each scan takes less than 4 minson an average for elderly people (>40 Years) and less than 2.8minutes foryoung people (<40 Years) demonstrating the ease of use. The signal strengthand Signal to Noise ratio is greater than the closest competition by at least
5%. The device encompasses cold OLED illumination allowing patient comfort
compared to other diagnostic methods. The device is tele-medicine ready andtherefore can be screened patients in tele-ophthalmology platform.

Present stage of Development
The pre clinical product named IXanner AEAR is already in the market. The
clinical product is in the process ofobtaining regulatory certificates
Geographical Region Targeted:
India, Asian and African Developing
nations

Unique Selling Point: The world’s only device that can perform comprehensive
eye screening at site. Scanning patients from neonates to centennial

Cost:
16L INR for the entire device or 400Rs
per scan and a minimum of 400 scans.

Product Positioning: Use our services (Eye camps) conducted by a. Corporates
and hospitals b. Non-profit organizations and NGO’s. Use our Product for
Advanced diagnosis offered by a. Multi speciality eye centers b. Independent
Practitioners at rural and suburban regions.

Units sold:
IXanner AEAR – 2 units, Enctra OCT – 2
units, FPGA based OCT DAQ – 1 unit
IP Status:"SYSTEM AND METHOD FOR
ENHANCING ROBUSTNESS, QUALITY,EFFICIENCY, AND SIGNAL TO NOISERATIO IN SPECTROMETERS" – Filed 2.
“A method to reduce motion artefacts
in an optical coherence tomographysystem” - Filing in process.

National/Societal relevance: More than 66% population shall be benefitted
by IXanner.
Import Substitution: For the Current need, the possible imports are from
Zeiss, Topcon, Retcam, Optovue and Leica which are still very bulky and costs
more than 30 L INR
Export Potential: Very High (~5Cr a year with 4% growth).
Product Picture

Contact details

124

Major Achievements(including awards):
Nidhi Prayas in 2019, BIRAC Seed in
2020, BIRAC BIG in 2021, ELEVATE in
2022, Jan Care in 2022, Awarded by DST
through SAMEER for indigeneity of the
product, Awarded at NLS, conference
at IIT Kgp for contribution to deep techscience in India, Top 10 start ups from
MedTech Actuator

Emailravikiran@medevplus.com

Websitehttps://medevplus.com

Startup Name
Trestle Labs | Kibo

Product/Technology
Kibo - AI-powered solution to listen, translate, digitize andaudio’tize any kind of printed, handwritten and digital content

Unique Selling Point: 1. Language: While other products only support English
and other Latin-based languages, Kibo supports 60+ Global languages
including 13 Indian languages and covering 80% of world’s spoken languages.
2. Handwriting: While other products only support printed content, Kibo
supports handwritten content with accuracy up to 99% at times, such thatvisually-impaired professors use Kibo to assess the handwritten answer
sheets of their students independently.
3. Audio'tization (Text to MP3): While it currently takes 4-6 weeks forvolunteers to manually audio-record one 300-page book, with Kibo you canType, Scan or Upload content and convert it to MP3, even for Indian regional
language content.
4. Translation: While online translation services like Google Translate provide
translation only for accessible digital documents, Kibo provides translationeven for scanned image-based PDF files while saving 75% manual translation
time with its high accuracy translation output.
5. Multi-device access: While other solutions store content offline, Kibo uses
cloud storage to store and access documents across devices seamlessly
Product Positioning: Product is positioned as an assistive technology anddigital transformation tool for schools, colleges, universities, libraries andoffices.
National/Societal relevance:
1. GDP increase: an Increase of $3 billion in GDP by including 30 million
visually-impaired in the workforce
2. Reduced Economic burden: By making Visually-impaired people socioeconomically independent and shifting them from being welfare-recipients tobecoming active-contributors of the economy
3. Grass-root level change: Sustainable Grass-root level impact resulting inincreased GDP-prospects by 7.5% ($3 billion)
4. Reduced dependency: 37% lesser dependency on others for persons withblindness and vision-impairment
5. Lesser drop-out rates: with faster and easier access to educational
resources
6. Better prepared: for mainstream education, skilling and employment
Import Substitution: Yes
Export Potential: Already exporting to Singapore, Kenya, Ghana, Thailand,
Nepal, US, UK and Brazil

Present stage of Development
Commercially available (TRL-9)
Geographical Region Targeted:
GlobalCost:
Rs.47,000/- (Kibo XS device)

Units sold:500+ (Kibo XS device)

IP Status:
Patent Granted (Patent No.: 411804)

y
y
y
y
y

y
y
y

Major Achievements(including awards):
General Motors Prize at MIT Solve,
New York, USA, 2022
Patrick J. McGovern Foundation AI
for Humanity Prize at MIT Solve,
New York, USA, 2022
MIT Solver for the Class of 2022 at
MIT Solve, New York, USA, 2022
Winner, One Young World Lead2030
Challenge for SDG8 supported bySanten, Manchester, UK, 2022
Selected for Washington DC based
Halcyon Incubator’s Residential
Fellowship Program, Washington
DC, USA, 2022
Winner, DBS Social Enterprise
Grant, 2021
Winner, Prosus Social Impact
Challenge for Accessibility Grant,
2021
Selected for ‘Leaders In Innovation’
Advance Program by Royal Academyof Engineering, London, UK, 20212022

Product Picture

Contact detailAkshita Sachdeva
Mobile No: : +91 9654177418

EmailWebsitehttps://trestlelabs.com
125

126

Startup Name

Product/Technology

UNINO Healthcare Private Limited

PleuraGoh®

Present stage of Development
TRL4

Unique Selling Point:
1) PleuraGoh® patch a sutureless chest tube sealing and securement device
which prevents recurrence of trauma induced iatrogenic pneumothorax, it
reduces the complication related to air leak, tube dislodgement and infection
prevention.
2) PleuraGoh® Drain is an IoT and AI based portable drainage systemcomplementing pleuraGoh® patch, with remote monitoring, continuous
controlled auto suctioning and auto chating for early prognosis.

Geographical Region Targeted:
India, USA, UK, Middle East, South East
Asian and Japan

Cost:
Target cost INR 950

3) Novel Tech in PleuraGoh® drainage system entrap pathogens for the
purpose of enrichment and isolation, selectively from the fluids that enable
early detection. These pathogens are used for further testing and clinicalstudies and diagnosis at point of care
Product Positioning: PleuraGoh® improves patient outcomes, reduces costs,
increases hospitals productivity enabling them to provide care to large patient
populations. Trauma Surgeon, Cardio-thoracic Surgeon, Intensivist, and more
are the users. The patients needing plural drainage or with chronic disease
condition with malignant effusion are actual beneficiaries of the PleuraGoh®.

Units sold:Yet to Launch

IP Status:
Patent Granted: 370099 Title: Fluid
extraction device.

yNational/Societal relevance: One fourth cases of world tuberculosis are in
India and moreover, chest drain surgeries may be required for various otherconditions such as traumatic road accidents and non-traumatic like cardio
thoracic surgeries, respiratory infections and more. Low-cost, easy procedureand prevention of recurrence all this are majorly required on large tertiary
healthcare set-ups. PlueraGoh® Patch is a cost-effective solution which
prevents recurrence of surgeries and pleuraGoh® Drain acts as an Import
Substitute with added value at point of care with reduced time of treatment..
Import Substitution: YesyExport Potential: Traditional methods of care with the use of suture andgauze are globally used having its own set of complications. PleuraGoh®
addresses these complications and the only solution to prevent reoccurrenceof trauma induced pneumothorax. This has a good untapped potential in the
global market.
Product Picture

Contact detail

Mobile No: : +91 9819202145

WebsiteyyyMajor Achievements(including awards):
Featured in top 75 biotech women
entrepreneur in India in a coffee
book published by BIRAC DBT
celebrating 75 years of aazadi ka
amrit Mahotsav launched by Mr.
Jitender Singh, Minister of Scienceand Technology, GoI at Biotech
Startup Expo, 2022 inaugurated by
Mr. Narender Modi, Prime Ministerof India
Top 10 at CAHO (Consortium
Associationof
Hospital
Organization) Pitchfest, 2022
Top 10 - Pan India track, Conquest
cohort, 2022
Top 10 innovation, MakerMela 2022
Received BIRAC BIG Grant of Rs. 50
lac.

www.uninohealthcare.com
127

Startup Name

Product/Technology

Urban Air Labs

Ubreathe – Nature based technology for air purification

Unique Selling Point: Plant based air purification
National/Societal relevance: Air pollution is one of the most important topics
on a national level.
Export Potential: High
Product Picture

Present stage of Development
Early traction
Geographical Region Targeted:
Pan India
Cost:
Rs. 39,999/Units sold:More than 1000
IP Status:
6 patents filed in India andone PCT in Europe
Major Achievements(including awards):
BIG BIRAC awardee

Contact details

128

Shubham Sahu
Mobile No: : +91 83188 37539

Websitehttps://ubreathe.in/129Startup Name

Product/Technology

Vel Natural fibers

Banana fiber separator and banana fiber products

Present stage of Development
Ready to market and sold 7 units

Unique Selling Point: Entrepreneurs, NGOs, Farm products companies
Product Positioning: Agricultural farm area

Geographical Region Targeted:
Banana cultivation area

National/Societal relevance: National Importance.
Import Substitution: This fiber products reduce some import fibers

Cost:
Vary with output requirements

Export Potential: Huge demand for export

Units sold:7

Product Picture

IP Status:
Patent no.251438

Major Achievements(including awards):
We have received “L ramp award of
excellence 2006 and IISF award

Contact detail130

K. Murugan

EmailWebsitewww.bananasilkfiber.com

Startup Name

Product/Technology

Velmenni R&D Pvt Ltd

LiFi Technology

Unique Selling Point: LiFi is a fully networked indoor wireless technology
enabling the transfer of data through light. Using the visible/invisible partof the light spectrum it transmits data, unlike WiFi which operates on radio
frequencies. LiFi provides higher speed and secured communication incomparison to existing technologies such as Wi-Fi.
Product Positioning: The product has applications in creating stronger
Telecom Infrastructure (5G deployments). The startup has also createdcustom solution using same technology for Indian defense.
National/Societal relevance: The technology has been developed in India
which has global scale in Telecom sector.
Import Substitution: RF based technologies such as UBR Radio, E-Band
Radio, Microwave, Wi-Fi
Export Potential: The product has already been exported.
Product Picture

Contact detailPresent stage of Development
Commercial Grade Product launchedat IMC22
Geographical Region Targeted:
India, South-East Asia, Europe, USA
Cost:
USD 2000
Units sold:100+
IP Status:
Patent Granted in EU, pending in India,
US, Singapore, Australia.
Major Achievements(including awards):
Won National Entrepreneurship Award
2019 (A3 Category). Won Top 10
Innovator in India under 35 by MIT and
HT Media Group

Mobile No: : +91 8527599685

Emailinfo@velmenni.com

Websitewww.velmenni.com

131Startup Name

Product/Technology

Verdant Impact

Animal ICU-Provide digital livestock healthcare services

Unique Selling Point: Their cattle credit card product helps farmers in availing
credit products for their animals.
Product Positioning: Our solution monitors the storage conditions of bloodbags while it is transported and stored through RFID technology. Using oursolution we will be able to provide data regarding vein to vein that is fromdonor to patient along with end to end tracking and traceability that is madeavailable for Public and Private Hospitals to ensure safe and quality blood.
National/Societal relevance: They are increasing farmers income upto 400%
along with affordable healthcare service for livestock with bioscience based
intervention
Import Substitution: Too less

Product Picture132

Geographical Region Targeted:
India, South Africa, Europe,
North America
Cost:
INR 90
Units sold:1000600
IP Status:
Submitted

Export Potential: HighContact detailPresent stage of Development
In-Market

Major Achievements(including awards):
Won “ Best Emerging AgriTech Startup
Award” 2. Pashu Samriddhi Award,
Featured in top20 Startups in PM Kisaan
Sammelan2022

Mobile No: : +91 9672025828

Emailmanish@verdantimpact.com

Websitehttps://verdantimpact.com

133

134

Product/Technology

Startup Name
Yuvitel Technologies Pvt Ltd

System and Method for Mobile Healthcare Kiosk To
Bridge Out the Health Service Barriers
Present stage of Development
Pre-Commercialisation

Unique Selling Point: Doorstep Healthcare Solution
Product Positioning: B2B.
National/Societal relevance: The company provides affordable treatments
and diagnostics at doorstep in rural and remote locations, thereby providing
treatment to all.

Geographical Region Targeted:
Rural India
Cost:

Import Substitution: Yes

3,50,000.00

Export Potential: Yes

Units sold:5

Product Picture

IP Status:
409518Major Achievements(including awards):
INR 25 Lakhs grant funds raised

Contact details

Mobile No: : +91 9907522413

Websitehttps://okk247.com/

135

136